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1. Introduction 
1.1. Zoonosis and emerging diseases  
 
The World Health Organization (WHO) defines zoonosis as “any disease or infection 
that is naturally transmissible from vertebrate animals to humans and vice-versa”. 
Zoonotic agents may be viruses (Rabies virus), bacteria (Salmonella spp.), protozoa 
(Toxoplasma gondii) and helminths (Fasciola spp.). A disease is defined as emerging 
when it is “newly recognized or evolved, or has occurred previously but shows an 
increase in incidence or expansion in geographical, host or vector range”. The 
increasing discovery of zoonoses is often related to better diagnostic tools, but the 
main causes of their emergence are human behaviour and modifications of natural 
habitats. Animals, particularly wild animals, are thought to be the source of >70% of 
all emerging infections [1] of which 25% are of viral origin [2]. Expansion of human 
population results in encroachment into undisturbed habitats which may lead to 
increased exposure to wildlife and their associated pathogens. The disturbance of 
habitats by humans inevitably leads to a loss of biodiversity, which may indirectly 
increase the possibility of emerging diseases [3]. This phenomenon has been described 
as the “dilution effect”, postulating that a decrease in a host diversity leads to an 
increase of prevalence of infectious diseases and vice versa [4]. Furthermore, factors 
such as increased wildlife trade, live animal and bushmeat markets, and consumption 
of bushmeat provide an interface for pathogen transmission [5]. Additionally, 
globalization and associated increased global travel facilitate the global distribution of 
emerging pathogens within a few days [6]. Zoonotic viruses can be highly pathogenic 
for humans, however, the underlying factors that enable viruses to cross the species 
barrier are not known. In general, three factors are necessary for the establishment of a 
zoonotic virus. The host must be susceptible to the virus, the environmental conditions 
must provide stability and viability of the virus and the host, and the virus must come 
into contact frequently enough for a successful transmission [7]. It is believed that 
genetic relatedness of species favours cross-species transmission of pathogens [6, 8] but 
the intrinsic principles of these phenomenon are still not understood. For a successful 
transmission, viruses have to overcome ecological and molecular species barriers as, 
for example the virus entry by species-specific receptors. Even after the crossing of 
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receptor-dependent barriers, genome replication, gene expression and morphogenesis 
have to adapt to new intracellular environments. Moreover, the innate immunity of 
the new host needs to be evaded to establish a successful replication [9, 10]. Viruses 
with a broad host range can use different host cell mechanisms for replication and are 
therefore more likely to gain access to new hosts than viruses which are specialized in 
a single or closely related host [6]. Furthermore, it has been shown that it is more 
likely for a virus to adapt to humans when it has a broad range of life cycles and 
replication modes [11]. Another important factor are the transmission patterns of 
viruses which play an important role in the definition of ecological species barriers. 
Direct zoonotic virus transmission, for instance, can occur by saliva from reservoir 
animals, as in the case of rabies. More often viruses use vectors or intermediate 
amplifying hosts. Arthropod-borne viruses, like Alpha-, Bunya-, or Flaviviruses, are 
transmitted to humans via insects or ticks, which take up the virus when feeding on 
infected animals. Intermediate or amplifying hosts serve as bridges between two 
species, possibly facilitating stepwise adaptation and/or bringing the virus into contact 
with recipient hosts [6]. For example, Nipah virus is maintained in a bat reservoir, but 
use pigs as an amplifying host prior to transmission to humans [12]. The majority of 
the recently emerged zoonotic diseases were caused by RNA viruses. In comparison to 
DNA viruses, RNA viruses have an error-prone replication, insufficient or complete 
lack of proof-reading mechanisms and a short generation time [13]. These 
characteristics result in a more rapid genetic evolution of RNA viruses, which is 
believed to be crucial for successful transmission to a new host. Thus, cross-species 
transmission is more likely to happen if the virus has a RNA genome than a DNA 
genome.    
 
Bats are increasingly recognized as sources of emerging zoonoses and harbour a 
variety of highly virulent RNA viruses including Rabies virus, Ebola- and Marburg 
virus, severe acute respiratory syndrome (SARS) virus, Hendra- and Nipah virus. The 
question of whether bats are special in their potential to harbour zoonotic viruses is 
widely discussed [14-16]. A number of characteristics may enhance their suitability as 
virus reservoirs. Bats account for 20% of all mammals and live on all continents except 
Antarctica. They can live in large social groups with a high population density, have a 
relatively long lifespan, they often live in sympatry, leading to a greater interspecific 
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transmission and are mobile [15-17]. Viruses in bat populations exhibit significantly 
genetic diversity and there is a theory that bats have ancient relationships with these 
viruses and hence serve as reservoir.  
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1.2. Eidolon helvum 
 
Eidolon helvum (E. helvum), the straw-coloured-fruit bat, is the second largest fruit bat 
on the African continent and belongs to the family Pteropidae [18]. E. helvum is highly 
abundant in Sub-Saharan Africa with their primary habitat in the tropical forest and 
savannah. Their habitat stretches from Senegal in the west, across central Africa to 
Ethiopia in the east and down to South Africa in the south (Fig. 1). Colonies have also 
been recorded on several off-shore islands in the Gulf of Guinea, Zanzibar, Pemba and 
Mafia, on the Arabian Peninsular and has been sighted in Yemen and Saudi Arabia 
[18-20]. E. helvum form large colonies with up to 1 Million animals which use the 
same roosts and foraging areas over many years [21]. Each year, animals disperse into 
smaller colonies and migrate up to 2000 km along a south-north, north-south route 
following the rainfall gradient [18, 19, 22, 23]. E. helvum feed on fruits and blossoms  
 
 
 
Figure 1: E. helvum in the zoological garden of Kumasi and the habitat range of E. 
helvum. This species exist on the African continent only, and migrates over long 
distances crossing country borders. The colony, studied in this thesis, resides 
temporally in Kumasi (red star), Ghana. Foto: F.Gloza-Rausch. Map modified 
according to [24].  
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and migration coincide with blossoming and fruiting of specific tree species [23]. 
During migration, colonies arrive at roosting areas when fruit abundance is increasing 
and continue to migrate when fruit abundance is decreasing, following the seasonal 
abundance of local food resources [22, 23]. As a result of deforestation and the 
expansion of human settlements, E. helvum are increasingly roosting in urban areas 
getting in closer contact with humans [25, 26]. Fruit bats have long lifespans and low 
rates of reproduction. Mating occurs seasonally in April to July but gestation does not 
begin until October. Females typically give birth in maternity colonies to one pup 
(occasionally two) in February to late-March prior to the onset of rainfall season [18, 
27-29]. Increased use of urban habitats often creates conflicts with humans. Residents 
complain about noise and odour annoyance and depredation of crops. Hence E. 
helvum is often hunted, but not only for reasons of nuisance but also as a source of 
protein and income, if not used for self-consumption. In fact, E. helvum is one of the 
most hunted bushmeat in Sub-Saharan Africa. In Ghana, a minimum of 128,000 E. 
helvum bats are sold annually [26]. This is a serious concern, as fruit bats are essential 
for seed dispersal, pollination and the genetic connectivity of plants among fragmented 
patches of rainforest [22]. The resulting products of timber, fruit, fibres and tannins 
contribute significant to world markets and local economies [22].  
 
1.2.1. Viruses in E. helvum 
 
There is increasing evidence that E. helvum harbour a variety of viruses from different 
families. The first virus isolate from E. helvum was Lagos bat virus (LBV) from the 
genus Lyssavirus [30]. Later, antibodies against LBV were detected in colonies from 
Ghana [31, 32], Kenya [33] and Nigeria [34]. Antibodies against other members of the 
genus Lyssavirus, Rabies virus (Nigeria) and Mokala virus (Kenya, Ghana), were also 
detected [31, 33, 35]. In 2013, two related Rubulaviruses (Achimota 1 and 2) from the 
family Paramyxoviridae were isolated from a straw-coloured fruit bat in Ghana. The 
viruses are distantly related to the human pathogenic Mumps and Parainfluenza virus 
2 and 4. Serum of E. helvum from Ghana and the islands São Tomé, Principe and 
Annobón contained neutralizing antibodies against the two novel Rubulaviruses [36]. 
At least 20 other previously unknown Rubulaviruses circulate in E. helvum colonies 
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across Sub-Saharan Africa [16]. Henipaviruses have not yet been isolated from E. 
helvum, but there is evidence of a high diversity of henipa viruses in these animals [16, 
37], and serological cross-reaction and neutralization with Nipah virus and Hendra 
virus were observed [16, 38, 39]. Apart from an Orbivirus (family Reoviridae), which 
was isolated from a Nigerian straw-coloured fruit bat, there have been no other virus 
isolate from E. helvum until now [40]. However, metagenomic analysis’s suggest the 
presence of viruses from the families Reoviridae, Parvoviridae, Herpesviridae, 
Papillomaviridae, Adenoviridae, Poxviridae and Picronaviridae [41-43]. It is therefore likely 
that increased research effort will uncover higher diversity of viruses hosted by E. 
helvum. 
 
1.2.2. E. helvum colony in Kumasi 
 
This study was conducted in a colony of approximately 300,000 individuals which 
roosts temporally in Kumasi, Ghana. Their primary roosting side is the zoological 
garden of Kumasi, located in central Kumasi, next to Kejetia market, the largest 
market in Western Africa. “Animals were first observed in July 1992. In March 1993 
individuals were recorded in a coconut tree and spread within four weeks on more 
trees. In the following years, their number increased and roosting areas on prior 
neglected trees were occupied. Since 1995, almost all trees in the zoological garden of 
Kumasi were used as roosting areas” (pers. comm.). A second known roosting area, is 
the Botanical garden on the campus of the Kwame Nkruma University, at the 
outskirts of Kumasi. The colony visits Kumasi during its annual migration, typically 
arriving in October with increasing numbers until December. Although the colony size 
may fluctuate on a daily basis following available food resources, the roosting sites are 
occupied until at least April. Parturition occurs in March, but a small population of 
animals forms a resident population year-round. The colony has close contact with 
humans, being within the zoological garden and in close proximity to Kejetia market, 
and also on the university campus. Humans are exposed to urine and faeces of the 
bats, particularly workers of the zoological garden who both live and work there. 
Additionally, the animals are hunted for consumption and control reasons.  
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1.3. Paramyxoviridae 
 
Paramyxoviruses are enveloped, negative-sense single strand RNA viruses that are 
divided into two subfamilies, Paramyxovirinae and Pneumovirinae. The subfamily 
Paramyxovirinae, comprises five genera, namely Respirovirus, Rubulavirus, Morbillivirus, 
Henipavirus and Avulavirus. Prominent human pathogens within this subfamily, are 
Human respiratory syncytial virus (genus Pneumovirus), Measles virus (genus 
Morbillivirus) and Mumps virus (genus Rubulavirus). Viruses in the subfamily 
Paramyxovirinae, have been associated with a number of emerging diseases in humans 
and animals, in the past two decades [61-68]. In 1994, a novel paramyxovirus named 
Hendra virus, associated with respiratory disease in horses and humans, caused two 
outbreaks in Australia [69, 70]. In the second outbreak, a patient with contact to 
horses, that had died of severe respiratory syndrome, died from relapsing encephalitis 
[71, 72]. Hendra virus continues to cause re-emerging outbreaks in Australia. Nipah 
virus, is another novel Paramyxovirus, which emerged in Malaysia in 1998, causing an 
outbreak of febrile encephalitis among pig farmers. The outbreak was linked, later, to 
cases of respiratory and neurological disease in domestic pigs [73, 74]. Since then, 
Nipah virus has caused several outbreaks in Malaysia, Singapore, India and 
Bangladesh causing lethal outcomes in many cases. These two viruses were assigned 
to a novel genus, Henipavirus, within the Paramyxovirinae [75]. Until now, they are the 
only assigned viruses in this genus. Although, human cases have been linked to 
contacts with horses and pigs, Pteropus bats, commonly known as flying-foxes, are 
suggested as wildlife reservoir for both viruses [64, 76]. Evidence of Henipavirus 
infection, in flying-foxes of different species, was found in China [77], Thailand [78, 
79], Cambodia [80], Papua New Guinea [81], Madagascar [82] and Ghana [37, 39]. In 
Ghana, antibodies against henipaviruses were detected in domestic pigs [83]. 
However, none of the afore mentioned countries have reported Henipavirus outbreaks. 
The transmission route of henipaviruses is hypothesized to be via urine and saliva. 
Outbreaks are associated with Pteropus bats roosting in close proximity to horses and 
piggeries. The viruses are transmitted via droppings or contaminated fruits, to horses 
and pigs in which they are amplified and further transmitted to humans [84-86]. In 
Bangladesh, Pteropus bats feed on date palm sap and transmission of Nipah virus to 
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humans, consuming contaminated date palm sap, occurred [87]. The only cases of 
human-to-human transmission were reported from Bangladesh [88, 89]. Until now, no 
cases of direct bat to human transmission of henipaviruses are known. Recently, 
Cedar virus, a virus related to Hendra- and Nipah virus was isolated from an 
Australian fruit bat [90]. Antibodies to Cedar virus cross-react with Hendra and Nipah 
virus, but cross-neutralization was not observed. In experiments with ferrets and 
guinea pigs, which are susceptible to Hendra and Nipah virus, no clinical signs 
developed [90]. In the genus Rubulavirus seven novel, with fruit bat associated viruses, 
were detected in the recent years. Menangle virus was originally isolated from stillborn 
piglets in Australia [61]. The virus circulated briefly in piggeries before it was 
eradicated in 1999 [91]. However, two infected humans developed severe influenza-
like illness and rash [92]. Neutralizing antibodies were detected in Australian Pteropus  
 
 
 
 
Figure 3: Global distribution of Henipaviruses. Outbreaks of, Hendra- or Nipahvirus, 
were reported from Australia, Malaysia, Singapore, Bangladesh and India (red). 
Serological evidence and/or viral RNA of henipaviruses, in flying foxes, were detected 
in South-East Asia but also in Africa (brown). The distribution of Pteropus bats is 
shaded in yellow. Picture modified according to [93]. 
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bats and the virus was isolated from bats in 2012, linking Menangle virus to fruit bats 
[91, 94, 95]. In Ghana, two Rubulaviruses, Achimota 1 and 2, were isolated from fruit 
bats [36]. Achimota virus 1 and 2 neutralizing antibodies, were detected in several 
fruit bat colonies across Sub-Saharan Africa. Although neutralizing antibodies were 
detected in humans, no link to a disease was made [36]. Tioman virus, was isolated 
from a fruit bat of Tioman island, a small island off the east coast of Malaysia [96], 
and neutralizing antibodies in Pteropus were also detected in Madagascar [82, 96]. 
Tuhoko virus 1-3 from China, related to Menangle- and Tioman virus, have not yet 
been isolated but antibodies have been detected in Leschenault's rousette bats [97]. 
None of the mentioned viruses caused clinical signs of illness is bats. In humans, only 
infection with Hendra-, Nipah- or Menangle virus lead to the development of a 
disease. In the past, the detection and characterisation of novel viruses on the base of 
genetic information, was impossible. However, the development of deep sequencing 
and enhanced tools for molecular biology, are expected to lead to a rapidly increase in 
the detection of novel viruses.  
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1.4. Rhabdoviridae  
 
The family Rhabdoviridae contains >250 known rhabdoviruses, currently classified in 
six acknowledged genera (Lyssaviruses, Vesiculovirus, Ephemerovirus, Novirhabdovirus, 
Nucleorhabdovirus and Cytorhabdovirus). According to the International Committee on 
Taxonomy of Viruses (ICTV), three more genera are currently pending (Perhabdovirus, 
Sigmavirus and Tibrovirus) and >100 rhabdoviruses are still unclassified [44]. 
Rhabdoviridae are enveloped viruses, with a negative-sense single-stranded RNA and a 
typical bullet shape virion. The general genome structure is nucleocapsid (N) - 
phosphoprotein (P) - matrixprotein (M) - glycoprotein (G) - large protein (L), however 
a variety of rhabdoviruses contain genes between P - M, M - G and/or G - L. The 
complexity of the genome is increased with overlapping reading frames (ORF) within 
genes (e.g. P and G) or in novel ORFs, for some species [45]. All plant rhabdoviruses  
 
 
 
Figure 2: Comparison of the genome structure of representatives of different 
rhabdovirus genera. The reading frames for the conserved rhabdovirus genes N, P, M, 
G and L are depicted as open arrows, additional genes are shown in grey. The size of 
the genomes and the rhabdovirus genera are indicated. According to [46].  
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(Nucleorhabdovirus and Cytorhabdovirus) typically encode more than the usual five 
genes. At least one, and a maximum of four genes, are inserted between the P and M 
gene [47, 48]. Fish rhabdoviruses (some Vesiculorhabdoviruses and Novirhabdoviruses) 
have an additional gene between G and L. Ephemeroviruses encode additional genes 
between G and L [48]. Representatives of different rhabdovirus genera are shown in 
(Fig. 2). Universal phylogenetic trees of the Rhabdoviridae, are traditionally generated 
by using sequences of the N gene [49]. The degree of conservation decreases in the 
order N > L > M > G > P [47]. Each of the five individual genes is flanked by 
transcription initiation and termination/polyadenylation signals, which may be 
conserved among members of the same genus [47]. Between each transcription unit 
(gene and associated flanking signals) is a nontranscribed intergenic region that 
usually contains a single or dinucleotide sequence [e.g. G or GG in Tupaia 
rhabdovirus (TUPV)] [45]. Termini of rhabdoviruses are highly conserved with an 
inverse complementary sequence of 15-20 nt, rich in A/U content, at both ends. These 
regions contain the genomic and antigenomic promoters, essential for viral replication 
and transcription [50]. In mammalian rhabdoviruses, the terminal nucleotides are 
conserved as 5’-ACG/CGT-3’ [48, 50]. Rhabdoviruses have been shown to infect all 
organisms, except bacteria (mammals, reptiles, fish, insects, fungi, and plants), 
however, they are rarely associated with diseases in humans [51]. The majority have 
two natural hosts: either insect and plants or insects and vertebrates, although never all 
three [47]. Five of the six rhabdovirus genera contain viruses that are transmitted 
and/or hosted by insects. Only fish rhabdoviruses and Lyssaviruses are not maintained 
by insect hosts. It is therefore postulated that Rhabdoviridae evolved from an ancestral 
insect virus. The supergroup dimarhabdovirus (dipteran-mammal associated 
rhabdoviruses) summarise arthropod-transmitted animal rhabdoviruses. It comprises 
the genera Ephemero- and Vesiculovirus and a variety of unassigned rhabdoviruses. 
Included in this group are the viruses Bovine ephemeral fever virus (BEFV) [52], 
Kontonkan virus (KOTV) [53] and Vesiculo Stomatitis virus (VSV) [52-54] which 
cause severe disease in cattle. With the exception of Rabies virus, rhabdoviruses are 
generally not associated with diseases in humans. However, three viruses from the 
dimarhabdo supergroup cause fatal disease in humans. Chandipura virus (CHPV), has 
caused outbreaks of encephalitis in India, and has also been detected in Africa [55]. Le 
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Dantec virus [56] and the recently described Bas-Congo virus (BASV) [57], have 
caused individual cases of hemorrhagic fever in Africa. Three dimarhabdoviruses have 
been isolated from bats: Oita virus (OIRV) [58], Mount Elgon bat virus (MEBV) [59] 
which both originate from Kenya, and Kern Canyon (KCV) which was isolated from a 
North American bat [59]. These viruses form a monophyletic clade and are probably 
geographic variants, which are common for rhabdoviruses. In the genus Ephemerovirus, 
the Australian viruses Kimberley- and Adelaide river virus are probably geographic 
variants of the African Malakal- and Obodhiang virus [60]. So far, the role of bats in 
the evolution and transmission of rhabdoviruses is still unclear. 
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1.5. Aim of the thesis 
 
The focus on bats as reservoirs of potentially emerging diseases has increased in the 
last decades. Most studies focus on the detection of viruses without exploring their 
genetic diversity to lower taxonomic levels, for example, to genera and species within 
bat colonies. Even less is known about the ecology and transmission patterns of these 
viruses.  
 
The aim of this thesis is to investigate bat virus diversity and dynamics in a 
longitudinal approach. The 300,000 strong colony of E. helvum in highly populated 
Kumasi, Ghana, provides a study site where bat-human interaction occurs on a daily 
basis. The potential for zoonotic transmission is thus potentially high. Previous studies 
have shown a high diversity of Paramyxoviridae genera Henipa- and Rubulavirus in fruit 
bats. Therefore, investigation of the virus diversity in the E. helvum colony focused on 
these genera.  
 
For the study, an E. helvum organ collection was generated over a time frame of three 
years. E. helvum organs were screened for the presence of novel and known 
Paramyxoviridae, and virus sequences were compared to their abundance during the 
sampling time, their relation to other fruit bat viruses and distribution in different 
African countries. 
 
I aimed to isolate viruses from E. helvum and characterise virus abundance in the 
colony. Possible transmission pathways were investigated by testing for organ tropism. 
For isolated viruses, serological assays were established to define the serological status 
of the E. helvum colony and investigate potential cross-species transmission of bat 
viruses to livestock and humans.  
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2. Materials and Methods 
2.1. Materials 
2.1.1. Chemicals 
100 bp DNA ladder Life Technologies, Darmstadt, Germany 
2-Mercaptoethanol  
(β-Mercaptoethanol) 
Carl Roth GmbH + Co. KG, Karlsruhe, 
Germany 
ACCUGEN, RNAse free water Lonza Cologne, Cologne, Germany 
Acetic acid, 100%, Ph.Eur., reinst Carl Roth GmbH + Co. KG, Karlsruhe 
Agarose Broad Range Carl Roth GmbH + Co. KG, Karlsruhe 
Agarose GTQ Carl Roth GmbH + Co. KG, Karlsruhe 
Ampuwa® (sterile, pyrogen-free water) Fresenius Kabi, Bad Homburg, Germany 
Beta propiolacton  Ferak Berlin, Berlin, Germany 
Bovine Serum Albumin (BSA) New England Biolabs GmbH, Frankfurt, 
Germany  
Bovine Serum Albumin  Roche Diagnostics, Mannheim, Germany 
Bromphenol blue Sigma-Aldrich Chemie GmbH, Munich, 
Germany 
Carrier RNA (10 mg/mL) QIAGEN, Hilden, Germany 
Chloric acid (HCl) Carl Roth GmbH + Co. KG, Karlsruhe 
Coomasie PlusTM (Bradford solution) Thermo Scientific, Bonn, Germany 
Crystal Violet Carl Roth GmbH + Co. KG, Karlsruhe 
DAPI ProLong Gold antifade reagent  Invitrogen, Karlsruhe, Germany 
Disodium hydrogen phosphate – dihydrate 
(Na2HPO4-7H2O) 
Merck KGaA, Darmstadt, Germany 
dNTP set (dATP, dTTP, dGTP, dCTP) Invitrogen, Karlsruhe 
Ethanol ≥99.9% Carl Roth GmbH + Co. KG, Karlsruhe 
Ethidium Bromide (10 mg/mL) Carl Roth GmbH + Co. KG, Karlsruhe 
Ethylenediaminetetraacetic acid (EDTA) AppliChem, Darmstadt, Germany 
EUROIMMUN sample buffer EUROIMMUN AG, Lübeck. Germany 
Formaldehyde 37% Carl Roth GmbH + Co. KG, Karlsruhe 
Glycerol Carl Roth GmbH + Co. KG, Karlsruhe 
Ketamin 10% Medistar, Ascheberg, Germany 
LB-Agar (Lennox) Carl Roth GmbH + Co. KG, Karlsruhe 
Magnesium chloride (PCR) Invitrogen, Karsruhe 
Methanol (99%) Carl Roth GmbH + Co. KG, Karlsruhe 
Milk powder Carl Roth GmbH + Co. KG, Karlsruhe 
Natriumhydrogencarbonat Carl Roth GmbH + Co. KG, Karlsruhe 
Roti® -Histofix 4% (pH7) Carl Roth GmbH + Co. KG, Karlsruhe 
Sacharose Sigma-Aldrich Chemie GmbH, Munich 
Sodium hydroxide (NaOH) Carl Roth GmbH + Co. KG, Karlsruhe 
Tris hydroxymethyl aminomethane (Tris) Carl Roth GmbH + Co. KG, Karlsruhe 
Triton X-100 Sigma-Aldrich Chemie GmbH, Munich,  
Tween 20 Sigma-Aldrich Chemie GmbH, Munich 
Xylene cyanol FF Sigma-Aldrich Chemie GmbH, Munich 
Xyxlazin (Rompun®) Bayer, Leverkusen, Germany 
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2.1.2. Buffers and Solutions  
 
Name Ingredients 
6x Loading Dye 40g Sacharose 
 0.25 g Bromphenol blue 
 0.223 g EDTA 
 in 100 mL deionized water 
Crystal violet stock solution 10 g Crystal violet 
 50 mL Formaldehyde (37%) 
 100 mL Ethanol (99.9%) 
 350 mL deionized water 
Crystal violet working solution 100 mL Crystal violet stock solution 
 100 mL Formaldehyde (37%) 
 800 mL deionized water 
PBS-Tween 0.1% TweenR 20 
 10% 10x PBS 
 in deionized water 
Phosphate buffered saline (PBS) 10x, pH7.0  80 g NaCl 
 2 g KCl 
 26.8 g Na2HPO4-7H2O 
 2.4 g KH2PO4 
 adjust pH with 37% HCl 
 add 1 L deionized water 
 autoclave 
TBE 10x 121 g Tris 
 61.8 g boric acid 
 186.12 g EDTA 
 in 1L deionized water 
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2.1.3. Consumables 
 
12-well immunoslides 5mm Dunn Labortechnik GmbH, Asbach, 
Germany 
C-Chip, Disposable Neubauer improved 
counting chamber 
Biochrom AG, Berlin, Germany 
Cell culture flask with filter cap (25, 75, 
175 cm2) 
SARSTEDT AG & Co., Numbrecht, 
Germany 
Cell culture plate (48-well) SARSTEDT AG & Co., Numbrecht 
Cell culture plates (6-well, 24-well) SARSTEDT AG & Co., Numbrecht 
Cell scraper TPP Techno Plastic Products AG, 
Trasadingen, Switzerland 
Centrifuge tubes (15, 50 mL) SARSTEDT AG & Co., Numbrecht 
Cryotubes SARSTEDT AG & Co., Numbrecht 
LightCyclerR Capillaries (20 XL) Roche Diagnostics GmbH, Mannheim, 
Germany 
LightCyclerR480 Multiwell Plate 96, 
white 
Roche Diagnostics GmbH,Mannheim 
Master point Energie Cal 4,5 (.177) Industrias el Gamo, Barcelona, Spain 
Needles 21G Servopax GmbH, Wesel, Germany 
Nunc Maxi Sorp 96-well plates Thermo Fisher Scientific, Schwerte, 
Germany 
PCR reaction tubes (0.2 XL) SARSTEDT AG & Co., Numbrecht 
Pipette Tips (10, 20, 200, 1000 XL)  SARSTEDT AG & Co., Numbrecht 
Reaction tubes (1.5, 2 mL) SARSTEDT AG & Co., Numbrecht 
Scalpel (No 15, 11) Feather Safety Razor Co., Osaka, Japan 
Serological pipettes (1, 2, 5, 10, 25 mL) SARSTEDT AG & Co., Numbrecht 
S-Monovette EDTA K2 (10 mL) SARSTEDT AG & Co., Numbrecht 
Stericup and Steritop Vacuum Filter Cups 
(500 mL) 
Millipore GmbH, Schwalbach, Germany 
Syringe (1, 2, 5 mL) BD, Heidelberg, Germany 
Syringe Filter (0.2 μm) Pall Corporation, Ann Aror, USA 
UlltraClear tubes (15 mL, 50 mL) Beckman Coulter, Krefeld, Germany 
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2.1.4. Technical Equipment 
 
Equipment Type Source 
454 sequencer GS Junior Roche Diagnostics 
GmbH,Mannheim 
Air rifle Diana Panther 21 Mayer & Gummelsbacher 
GmbH, Rastatt, Germany 
Autoclave V120 Systec GmbH, Wettenberg, 
Germany 
Balance SPO 61 Scaltec Instruments GmbH, 
Göttingen, Germany 
Centrifuges Centrifuge 5424  
 
Eppendorf, Hamburg, Germany 
 Centrifuge 5810R  
 
Eppendorf, Hamburg 
 Sorvall Evolution RC Thermo Fisher Scientific, 
Schwerte 
Chemiluminescence 
reader 
SynergyTM 2 BioTek, Bad Friedrichshall 
 Spectramax 190  Molecular Device, Sunnyvale, 
USA 
Dryshipper MVE SC 20/12 V German-cryo®GmbH, Jülich 
 SC 4/2 Germany 
 XC 20/3 V  
Freezer -20°C Liebherr premium Liebherr, Biberbach a. d. Ris, 
Germany 
 -80°C/Typ499 Kaltis Europe GmbH, 
Niederweningen, Switzerland 
 Liquid Nitrogen LS 750 Taylor Wharton Germany 
GmbH,Husum 
Gel electrophoresis PerfectBlue Gelsystem 
MaxiS 200 mL 
PEQLAB Biotechnologie 
GmbH, 
Erlangen, Germany 
Gel electrophoresis 
documentation 
E-Box 3028, WL/26M Vilbert Lourmat, Marne-la-
Vallee, France 
Heating block Thermomixer comfort Eppendorf, Hamburg 
Hood (Bioflow) HeraSafe Thermo Fisher Scientific, 
Schwerte 
Incubators HERAcellR 240 Thermo Fisher Scientific, St. 
Leon-Roth, Germany 
 HeraeusR B6126 Thermo Fisher Scientific, St. 
Leon-Roth 
Microscopes TELAVAL31 Carl Zeiss GmbH, Jena, 
Germany 
 IMAGER.M1 Carl Zeiss GmbH, Jena 
PCR cycler Mastercycler epgradient S Eppendorf, Hamburg 
pH meter 766 Calimatic Knick Elektronische Messgeräte 
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GmbH & Co. KG, Berlin, 
Germany 
Photometer NanoDrop 2000c PEQLAB Biotechnologie 
GmbH, 
Erlangen 
 Biophotometer Eppendorf, Hamburg 
Pipette assistance Accu-jetR pro Brand, Wertheim, Germany 
Pipettes Research, PhysioCare 
(100-1000 μL, 20-200 μL,2-
20 μL, 0.5-10 μL) 
Eppendorf, Hamburg 
Power supply EV202 Consort, Turnhout, Belgium 
Real-time PCR 
cycler 
LightCyclerR 1.5 Roche Diagnostics GmbH, 
Mannheim 
 LightCyclerR 480 Roche Diagnostics GmbH, 
Mannheim 
Rocking Block Mini Rocker MR.1 PEQLAB Biotechnologie 
GmbH, 
Erlangen 
Rotor SW40 Ti, SW41 Ti Beckman Coulter, Krefeld, 
Germany 
Tissue Lyser Qiagen Retsch Inc., Newtown, USA 
Ultrazentrifuge Optima L-80 XP Beckman Coulter, Krefeld 
Vortexer Vortex VF2  IKAR-Werke GmbH & CO. 
KG, 
Staufen, Germany 
Water purification 
system 
Milli-QR Biocel Millipore GmbH, Schwalbach, 
Germany 
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2.1.5. Cell culture media and supplements 
 
Amino Acids Non Essential (100x, 50 mL) PAA Laboratories GmbH, Cölbe  
Amphotericin B (250μg/mL) PAA Laboratories GmbH, Cölbe 
Avicel RC581 FCM BioPolymer, Brussels, Belgium 
CryoMaxx S (50 mL) PAA Laboratories GmbH, Cölbe 
Dulbecco's Modified Eagles Medium (high 
glucose, 4.5 g/L, 500 mL) (DMEM) 
PAA Laboratories GmbH, Cölbe 
Dulbecco's PBS without Mg/Ca(1x, 500 mL) PAA Laboratories GmbH, Cölbe 
Earl MEM (9.69 g/L) Biochrom AG, Berlin, Germany 
Fetal Calf Serum (FCS) “Standard” (100 
mL) 
PAA Laboratories GmbH, Cölbe 
Imipinem/Cilastin (Zienam ®) (500 mg) MSD Sharp&Dohme GmbH, Haar, 
Germany 
L-glutamine (20 mM, 50 mL) PAA Laboratories GmbH, Cölbe 
OptiPROTM serum-free medium (1 L) Life Technologies, Darmstadt, 
Germany 
Penicillin/Streptomycin (100x, 50 mL) PAA Laboratories GmbH, Cölbe 
Sodium pyruvat (100 mM, 50mL) PAA Laboratories GmbH, Cölbe 
Trypsin EDTA (1x, 50 mL) PAA Laboratories GmbH, Cölbe 
 
 
2.1.6. Cell lines 
 
Name Source 
Vero E6 Monkey kidney cell line (ATCC® CRL-1586) 
Vero FM Monkey kidney cell line (kind gift of Jindrich Cinatl, Universtiy of 
Frankfurt) 
MA104 Monkey kidney cell line (cell culture collection Bernhard Nocht-Institute 
for Tropical Medicine, Hamburg) 
A549 Human lung carcinoma cells (ATCC®CCL-185) 
EidNi Eidolon helvum kidney cell line (home made) 
EidLu Eidlon helvum lung cell line (home made) 
 
 
2.1.7. Antibodies 
 
Donkey-anti-goat Cy2 Dianova, Hamburg, Germany 
Donkey-anti-sheep Alexa Fluor488 Dianova, Hamburg 
Goat-anti-bat antibody IgG Bethyl Laboratories, Montgomery, USA 
Goat-anti-bovine Alexa Fluor488 Dianova, Hamburg 
Goat-anti-human Cy2 Dianova, Hamburg 
Goat-anti-swine Alexa Fluor488 Dianova, Hamburg 
Goat-α-bat-HRP Dianova, Hamburg 
Goat-α-human-HRP Bethyl Laboratories, Montgomery 
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2.1.8. Oligonucleotides 
 
Hemi-nested reverse transcription (RT) PCR 
 Paramyxoviridae 
RES-MOR-HEN-F1 TCI TTC TTT AGA ACI TTY GGN CAY CC 
RES-MOR-HEN-F2  GCC ATA TTT TGT GGA ATA ATH ATH AAY GG 
RES-MOR-HEN-R  CTC ATT TTG TAI GTC ATY TTN GCR AA 
AVU-RUB-F1 GGT TAT CCT CAT TTI TTY GAR TGG ATH CA 
AVU-RUB-F2 ACA CTC TAT GTI GGI GAI CCN TTY AAY CC 
AVU-RUB-R  GCA ATT GCT TGA TTI TCI CCY TGN AC 
PNE-F1 GTG TAG GTA GIA TGT TYG CNA TGC ARC C 
PNE-F2  ACT GAT CTI AGY AAR TTY AAY CAR GC 
PNE-R GTC CCA CAA ITT TTG RCA CCA NCC YTC 
  
 Colony PCR 
M13mod-F GTAAAACGACGGCCAGTGAAT 
M13mod-R CACACAGGAAACAGCTATGAC 
 
Real time RT PCR  
 Kumasi rhabdovirus 
BtRhabdoM17-rt F CTGACTATCGCGACATGCTGTAC 
BtRhabdoM17-rtP FAMa-ACACGGCGAAAGATCATGCCAAACA-BHQ1b 
BtRhabdoM17-rt R  TCCATTGCTCTCTGGCTCAA 
  
 Henipa-like viruses 
Spl6RMH-F CGGGATAGACATGGAGGTGTGT 
Spl3+6RMH-P FAM-CCITCTTGTTTCCTTCCTGATCATGCATC-BHQ1 
Spl6RMH-R  CCGTTCATCTTTTTGGATTTGAT 
Spl3RMH-F CGAGATAGACATGGAGGTGTATG 
Spl3+6RMH-P FAM-CCITCTTGTTTCCTTCCTGATCATGCATC-BHQ1 
Spl3RMH-R TTCTGCGCAATCCTCTATTGTCA 
Spl2RMH-F TTTACCCTTCCATCAACCTACGTT 
Spl2RMH-P  FAM-CAACCCTCCTCAATCGTCCACTTCCA-BHQ1 
Spl2RMH-R TCTGTGTCCTTTAGATATTCTCCTGATATT 
Spl33nRMH1-F  TGGTGTCTGGCCTCCTATGAA 
Spl33nRMH1-P  FAM-TTCCCCAGGCATGTTTCAAATACCATCA-BBQc 
Spl33nRMH1-R  CATATGTAAGTCTGTCTCCAGATGATTG 
Spl28nRMH2-F AGATAGACACGGAGGGATTTGG  
Spl28nRMH2-P  FAM-TGCAAACTTCCAGATCATTGTTCACCTCA-BBQ  
Spl28nRMH2-R TCTCCGTTCATTTTTTTGCTTTT 
PVSpl43RMH-F  TTGTGGCACCATAATAAATGGATT  
PVSpl43RMH-P  FAM-ACTTGGCCTCCTTGCGAACTTCCTG-BHQ1 
PVSpl43RMH-R CTCTTAACCAGAGCAGAAGCATGA 
PV-Spl90-69RMH-F GTTCAGAGACAGACATGGAGGTATGT  
PV-Spl90-69RMH-P FAM-TGTGACCTCCCTCCACATTCTTCACCTC-BHQ1  
PV-Spl90-69RMH-R TGGATAAGGACTCAGCATTAAGTTGT 
PV-Spl67-51RMH-F TTTGTGGGACAATTATCAATGGAT  
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PV-Spl67-51RMH-P  FAM-TGGCACCTGGCCACCATGTTCTCT-BHQ1 
PV-Spl67-51RMH-R TTTTTATAAGAGGTGAAGCATGATGTG 
PV-Spl48-55-91-27a-F  AAGCTTTGTCTCCCATTAAATCACA  
PV-Spl48-55-91-27a-P  FAM-AATGCCAACATGAAATACACACCAAAGCCT-BHQ1 
PV-Spl48-55-91-27a-R GGTTCAAACTCAGCATCATTGATAA 
PV-Spl63-65-F  CAGTCCTTAATTGGCGTTCGTT 
PV-Spl63-65-P FAM-ATTGGGTTCAAATTTGGTGTAT-MGBNFQd 
PV-Spl63-65-R  TCACTATCGAGGTCTAAGGGCATA 
PV-F7-F  AAAGCTCTTGCTGCGATAAGGA  
PV-F7-P  FAM-TGAGTGGGACAGTGTTT-MGBNFQ  
PV-F7-R  GTTGGCTGGTAAGAGAGATTTTCC 
  
aFAM, 6-carboxyfluorescein; bBHQ1, Black Hole Quencher1, cBBQ, Black Berry Quencher, dMGB, 
Minor Groove Binder; NFQ, Non-fluorescent Quencher, R=G/A, Y=C/T, S=G/C, W=A/T, 
H=A/C/T, N=any base, I=inosine 
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2.1.9. Enzymes 
 
Platinum®Taq DNA Polymerase Invitrogen, Karlsruhe 
SuperScriptTM III One-Step RT-PCR 
System with Platinum Taq DNA 
Polymerase 
Invitrogen, Karsruhe 
 
 
2.1.10. Kits 
 
cDNA Synthesis Kit Roche Diagnostics GmbH, Mannheim 
GeneRacer Kit LifeTech, Carlsbad, USA 
GS FLX Titanium Rapid Library 
Preparation Kit 
Roche Diagnostics GmbH, Mannheim 
MegaScript T7® Kit Invitrogen, Karlsruhe 
NucleoSpin® RNA II Macherey-Nagel, Düren, Germany 
NucleoSpin® RNA virus Macherey-Nagel, Düren 
QIAamp MinElute Virus Spin QIAGEN, Hilden 
QIAamp RNeasy® Mini Kit QIAGEN, Hilden 
QIAamp Viral RNA Mini Kit QIAGEN, Hilden 
QIAprep Spin Miniprep-Kit QIAGEN, Hilden  
SeqLab  Sequence Laboratories, Göttingen, 
Germany 
TOPO® TA Cloning® kit  Invitrogen, Karlsruhe 
 
 
2.1.11. Software 
 
Adobe Photoshop CS4 
AxioVision Rel. 4.8 
BEAST V1.7.4 
BioEdit Sequence Alignment Editor version 7.0.5.3 
Coral DRAW® X3 
DNASTAR Lasergene 7 (EditSeq, SeqMan) 
EpiInfo V7  
Gen5 
Geneious 5.1 
MAFFT V7 
MEGA 5.2 
MrBayes V.3.1 
Newbler software (Roche) 
SOFT max Pro 3.0 
IBM SPSS Statistics 22. 
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2.2. Methods 
2.2.1. Field sampling 
 
For all capturing and sampling, permission was obtained from the Wildlife Division, 
Forestry Commission, Accra, Ghana. Ethical approval for human samples was 
provided by the Committee on Human Research, Publications and Ethics Kwame 
Nkrumah University of Science and Technology, Kumasi, Ghana. Samples were 
exported under a state contract between the Republic of Ghana and the Federal 
Republic of Germany, and export permission from the Veterinary Services of the 
Ghana Ministry of Food and Agriculture. All samples were transported in liquid 
nitrogen. Between 2009 and 2012, the E. helvum colony in Kumasi was visited once a 
week in the months October to April. On average twelve animals were sacrificed per 
week. Identification and capturing was done by trained field biologist. Animals were 
shot from trees with an air rifle, anesthetised with a Xylazin:Ketamin (1:4) mixture 
and blood was taken by heart puncture. The carcasses were transported on ice to the 
close by Kumasi Centre for Collaborative Research were spleen, liver, kidney, 
intestine, gut, lung and brain were dissected. Aliquots of each organ were directly 
snap-frozen and preserved in 4% formaldehyde. Urine samples were collected in June 
2011 by placing a clean plastic sheet under a tree visited by E. helvum. Droppings were 
collected directly and stored at 4°C for transport and frozen at -80°C. In July 2011, 
blood samples were taken by trained phlebotomists from people working at the 
Zoological gardens of Kumasi after obtaining informed consent from all participants. 
Livestock samples were taken in December 2011 by trained veterinarians. Generally, 
blood was drawn from the vena jugularis externa. Animals originated from Kumasi 
and surrounding areas. All sera were collected in EDTA Monovettes. Samples were 
stored at 4°C for several hours before sepearation by centrifugation at 2,500 x g for 10 
minutes and aliquoted and stored at -80°C.  
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2.2.2. Cell culture methods, virus isolation and propagation 
2.2.2.1. General cell culture methods 
 
Cell lines were maintained in DMEM supplemented with 10% fetal-calf serum (FCS), 
1% penicillin-streptomycin, 1% sodium pyruvate, 1% non-essential amino acids and 
1% L-glutamine (hereafter referred to as supplemented DMEM) at 37°C, 5% CO2. 
According to cell growth, cells were passaged one to three times a week. Supernatant 
was removed, cells were washed with PBS and incubated with trypsin at 37°C until all 
cells detached from the surface. Trypsin was inactivated by resuspending cells in 
culture medium and cells split in ratios between 1:3 and 1:10 depending on cell 
growth.  
 
2.2.2.2. Virus isolation 
 
For the isolation of viruses from E. helvum, two heterogeneous cell lines derived from 
the lungs and kidneys of E. helvum were applied. In addition, VeroE6 cells were used 
as many viruses were previously isolated on this cell line (Lassavirus, Measles virus, 
Ebola virus, Crimean-Congo hemorrhagic fever virus, SARS virus) [98]. Body 
temperature of fruit bats are in the range of 30°C to 40°C with an average of 34°C to 
37°C [99]. However, the effect of the temperature on bat virus growth is not known. 
Hence the temperature was maintained at 37°C which is the normal temperature for 
mammalian cell lines. Bat viruses are thought to be highly adapted to their hosts. A 
frequently observed pattern for these kind of viruses is the persistence or long-term 
replication in lymphatic organs as the spleen [16]. Therefore, the spleen was the organ 
of choice for virus isolation experiments. 
 
2.2.2.3. Undirected virus isolation 
 
The spleen of ten E. helvum from the year 2010 were inoculated on a mixture of 
EidNi/EidLu (1:1) cells and VeroE6 cells. Spleen were homogenized with the back of 
a syringe, frozen and thawed on ice. 5 x 104 cells/ml were seeded in 24-well plates. 
The Spleen suspension was centrifuged for 10 minutes at 300 x g, cells washed with 
PBS and infected with 200 μL cleared spleen suspension. Inoculum was removed after 
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1h of incubation at 37°C, 5% CO2, cells washed with PBS and incubated in 1 mL 
supplemented DMEM with 5% FCS. Cells were observed daily for formation of CPE. 
Samples were blind-passaged six days post infection with 200 μL supernatant to fresh 
cells if no CPE formed. After six passages without formation of CPE virus isolation 
was closed. CPE positive samples were passaged with 200 μL supernatant on fresh 
VeroE6 cells, with each passage the cell area was increased to increase virus titre and 
volume.  
 
2.2.2.4. Directed Virus isolation 
 
Directed virus isolation was approached as described in undirected virus isolation 
(2.2.2.3.) but spleen were pre-tested with a genus-specific PCR (2.2.6.1.) for 
Paramyxoviridae. 12 spleen positive for the genus Henipavirus were used as inocula for 
virus isolation. In addition, 12 E. helvum urine samples positive for the genera 
Henipavirus, Avulavirus and Respirovirus were used. Urine (10-50 μL) was diluted in 850 
μL supplemented DMEM. VeroE6, EidNi and EidLu cells were infected with 200 μL 
urine/medium mixture. The remaining sample was filtered through a 0.2 μm pore 
filter and cells infected with 200 μL cleared sample. After incubation at 37°C, 5% CO2 
for 1h, 1mL supplemented DMEM with 5% was added and cells incubated at 37°C in 
5% CO2. Cells were observed daily for formation of CPE and blind passaged with 200 
μL supernatant to fresh cells if no CPE showed. If no CPE formed after six passages 
cell cultures were discarded. 
 
2.2.2.5. Production of virus stock 
 
VeroFM cells were seeded in a T163 flask (1x107 cells), infected with a multiplicity of 
infection (MOI) of 0.01 in 10mL OptiPROTM (serum free medium) and incubated for 
1h at 37°C, 5% CO2. 10 mL supplemented DMEM was added and cells incubated at 
37°C, 5% CO2 for two days. Supernatant was harvested, cells opened with one cycle of 
freeze-thawing and resuspended in the virus-containing supernatant. Virus stock was 
cleared by centrifugation at 300 x g for 10 minutes, aliquoted and stored at -80°C until 
required. 
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2.2.2.6. Concentration of viral particles  
 
Virus was produced as described in 2.2.2.5. but directly used for ultracentrifugation by 
one of two available systems depending on volume. For small volumes, 2 mL 36% 
saccharose was overlaid with 16 mL supernatant and centrifuged in a SW40 Ti rotor 
at 28,000 x g for 4h at 4°C. Large volumes were centrifuged in a SW41 Ti rotor with 5 
mL 36% saccharose and 20 mL supernatant at 28,000 x g for 4h at 4°C. After 
concentration, supernatant was removed and the pellet resuspended in 200 μL 1x PBS 
overnight. Depending on the requirements for further experiments, viruses were 
inactivated by incubation in 2% paraformaldehyde (Pfa) for 20 minutes, inactivation 
buffer of the respective kit or with 0.1% β-propiolacton at 4°C overnight followed by 
2h at 37°C.  
 
2.2.2.7. Purification of viral particles 
 
For 454 sequencing it is necessary to reduce the cellular background as much as 
possible. Therefore, viral particles were cleared on a saccharose gradient. 
Concentrated viral particles (2.2.2.6.) were overlaid on a saccharose gradient ranging 
from 10% to 60% and ultracentrifuged in a SW40 Ti rotor at 28,000 x g for 12h at 4°C. 
Fractions of 500 μL each were collected; RNA was extracted from an aliquot of 70μL 
for each fraction (2.2.5.4.) and tested in real-time RT-PCR (2.2.6.2.) for viral 
concentration. Fractions with the highest RNA concentrations were pooled and 
concentrated according to 2.2.2.6. of viral particles. 
 
2.2.2.8. Detection of viral particles in cell culture 
 
Virus was prepared as described in 2.2.2.6. and inactivated in 2% Pfa. Inactivated 
virus was sent to Andreas Kurth at the Robert Koch Institute in Berlin, by whom 
electron microscopic analysis and image capture of viral particles was done. 
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2.2.2.9. Plaque titration assay 
 
VeroFM cells were seeded with a concentration of 4 x 105 cells/mL (0.5 mL/well) in a 
24-well plate and incubated over night. Cells were washed with 1x PBS. Virus stock 
was diluted from 10-1 to 10-6 in OptiPROTM. For each dilution 200 μL were applied on 
cells in duplicates and incubated for 1h at 37°C in 5% CO2. Supernatant was removed, 
cells washed with 1x PBS and overlaid with 500 μL of 2x MEM supplemented with 
2% penicillin/streptomycin and 4.4 g/L NaHCO3 / 2.4% Avicel (60:40) Cells were 
incubated for 4 days at 37°C in 5% CO2. Overlay was removed, cells fixed in 6% Pfa 
for 20 minutes and stained with crystal violet solution for 10 minutes. Depending on 
virus concentration, plaques were counted for all countable dilutions and the titre was 
calculated according to the following equation 
 
 
  
 
2.2.2.10. Virus kinetic 
 
VeroFM, EidNi, EidLu, Ma104 and A549 cells were seeded in 6-wells (8 x 105 cells), 
infected with a MOI of 0.001 and incubated for 1h at 37°C. Supernatant was removed, 
cells washed with 1x PBS and incubated in supplemented DMEM. Supernatants and 
cells infected with Kumasi rhabdovirus were collected at 0, 8, 24, 48, 72, and 96h post 
infection for RNA extraction and virus titration. RNA extraction and real-time RT-
PCR were done as described above.  
 
2.2.3. 454 sequencing of KRV 
 
Full genome sequence of Kumasi rhabdovirus was done by de novo sequencing using 
454 Life Sciences technology. A T163 flask Vero FM cells was infected with a MOI of 
0.01 with Kumasi rhabdovirus and incubated at 37°C and 5% CO2 for two days. 
Supernatant was harvested and cells lysed by one freeze-thaw cycle. Cells and 
supernatant were clarified at 300 x g for 5 minutes. Supernatant was applied to a 
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succhrose gradient ranging from 10-60% and ultracentrifuged with a SW40 Ti rotor at 
28,000 x g for 21h at 4°C. Fractions of 0.5 mL were collected, analysed by real-time 
RT-PCR (2.2.6.2.) and fractions with highest viral RNA concentration were pooled. 
Pooled fractions were clarified at a 36% succhrose cushion at 28,000 x g for 4h at 4°C, 
the pellet dissolved in 500 μL PBS overnight and viral RNA extracted according to 
(2.2.5.4.).  
 
RNA was extracted using viral RNA kit without carrier RNA (Qiagen). RNA was 
reverse transcribed and double-strand cDNA was sythesized using a cDNA Synthesis 
System Kit (Roche). 500 ng of double stranded (ds) cDNA was fragmented according 
to the Roche GS Junior Rapid Library Preparation Method Manual. Fragment ends 
were repaired, 454 sequencing adaptors were ligated and emulsion PCR was 
performed according to the standard 454 sequencing protocols (Roche). Next 
generation sequencing of the library was performed with a Genome Sequencer Junior 
(Roche).  
 
Reads were de novo assembled using the Newbler software (Roche) and resulting 
contigs were aligned against the non redundant NCBI database with the blastn, blastx 
and tblastx algorithms [100]. 
 
The novel rhabdovirus sequence was confirmed by generating overlapping RT-PCR 
amplicons using primers that were designed based on a 10,982 bp long contig that 
showed similarities to other rhabdovirus sequences. Sequencing of RT-PCR products 
was performed using the Sanger method. Genome ends were generated by use of a 
GeneRacer Kit (LifeTech). 
  
2.2.4. Serological methods 
2.2.4.1. Enzyme-linked-immunosorbent assay (ELISA) 
 
Bat and human samples were pre-screened with an in-house enzyme-linked 
immunosorbent assay (ELISA) for antibodies against KRV. 96-well plates 
(NuncMaxiSorp) were coated with 0.4 μg virus antigen in 0.1 M NaHCO3-buffer (pH 
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9.6) and blocked with 5% milk powder in PBS 0.1% Tween20. Sera were diluted 1:100 
in 1% milk powder in 1x PBS 0.1% Tween20 and incubated for two hours. Detection 
was done with goat-anti-bat immunoglobulin (Ig) horseradish peroxidase (HRP) 
labeled (Dianova, Hamburg, Germany) (1:2,000), goat-anti-human (Ig) HRP labeled 
(Bethyl Laboratories Inc.) (1:4,000), respectively. 3,3’,5,5’-Tetramethylbenzidine 
(TMB) substrate was added, reaction stopped with 2 M sulfuric acid and absorption 
measured at 450 nm and 630 nm on either Synergy 2 Multi-Mode Microplate reader 
(BioTek) or Spectramax 190 (Molecular Device). Data were analysed with Gen5 or 
SOFT max Pro 3.0 software. Cut-off was calculated by tripling the optical density 
values of the negative control. 
 
2.2.4.2. Indirect immunofluorescence assay (IFA) 
 
Bat, livestock and human sera were screened with a KRV specific 
immunofluorescence assay. VeroE6 cells were infected with an MOI = 0.1 in 
supplemented DMEM and incubated for two days. Cells were mixed 1:1 with non-
infected cells (1.2 x 106 cells/mL) spottet on 12-well immunoslides (Dunn 
Labortechnik GmbH), air-dried and fixed in ice-cold methanol:acetone (1:1). Sera 
were diluted 1:40 and detection was done with either goat-anti-bat antibody Ig (Bethyl 
Laboratories) 1:1,000 followed by donkey-anti-goat cyanine 2 (Cy2) labeled Ig 
(Dianova) 1:100 for bat samples or goat-anti-human Cy2 labeld Ig (Dianova) 1:400 for 
human samples or Goat-anti-swine Alexa Fluor488 Ig (Dianova), goat-anti-bovine 
Alexa Fluor488 Ig (Dianova), Donkey-anti-sheep Alexa Fluor488 Ig (Dianova) 1:200, 
respectively for livestock samples. Slides were analysed and pictures taken with a 
Motic fluorescence microscope (Zeiss). 
 
2.2.4.3. Plaque-reduction-neutralization assay (PRNT) 
 
Sera were heat inactivated at 56°C for 30 minutes. All sera were assayed two in 
parallel in two-fold dilutions ranging from 1:10 to 1:320 for the final dilutions. 
Dilutions were mixed with approximately 23 PFU per well and incubated for 1h at 
37°C, 5% CO2. 1 x 105 VeroFM cells in supplemented DMEM were seeded in 48-well 
plates, incubated overnight and washed once with 1x PBS before addition of 100 μL 
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serum-virus dilution. After 1h incubation at 37°C, 5% CO2 supernatant was removed, 
cells washed with 1 x PBS and overlaid with 2.4% Avicel/2x MEM supplemented 
with 4,4 g/L NaHCO3, 20% FCS and 2% penicillin-streptomycin (40:60) and 
incubated for four days at 37°C, 5% CO2. Thereafter, cells were washed with 1x PBS, 
fixed with 6% paraformaldehyde for 20 minutes and the cell layer stained with crystal 
violet. Plaques were counted and the 50% neutralization titre calculated. Neutralizing 
titres of 1:10 were interpreted as borderline.  
 
2.2.4.4. Determination of protein concentration 
 
Protein concentration was determined according to Bradford Assay [102]. A serial 
dilution of albumin ranging from 2 mg/ml to 0.0312 mg/mL was used as standard. In 
brief, 12.5 μL of sample was mixed with 375 μL CoomasiePlusTM Protein Assay 
Reagent and incubated at room temperature for 10 minutes. Absorption was measured 
at 595 nm in a photometer and concentration determined by extrapolation in the 
standard curve.  
 
2.2.5. Molecular biological methods 
2.2.5.1. Isolation of viral RNA from tissue and mosquitoes  
 
Viral RNA was isolated with QIAamp RNeasy kit (Qiagen) according to 
manufacturer’s instruction. In brief, approximately 50 mg tissue, 10 mosquitoes 
respectively were mixed with 600 μL lysis buffer containing 6 μL β-mercaptoethanol. 
Samples were homogenized at 30 1/s for 3 minutes in a tissue lyser (Qiagen). Samples 
were incubated for 2 minutes on ice, 600 μL 70% ethanol was added, mixed, applied 
to columns and centrifuged at 8,000 x g for 30 seconds. Membrane was washed with 
700 μL RW1 and 500 μL RPE with a spin at 8,000 x g for 30 seconds. The final wash 
was done with 500 μL RPE followed by centrifugation at 20,000 x g for 2 minutes. 
Column was dried at 20,000 x g for 5 minutes and RNA eluted with 100 μL 80°C 
RNase-free water at 8,000 x g for 1 minute after incubation for 4 minutes. Samples not 
directly processed were stored at -80°C. 
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2.2.5.2. Isolation of viral RNA from serum  
 
RNA from serum samples was isolated with QIAamp MinElute Virus Spin Kit 
(Qiagen) according to manufacturer’s instruction. In brief, 140 μL serum was mixed 
with 25 μL QIAGEN Protease and 200 μL AL buffer and incubated at 56°C for 10 
minutes. 5.6 μg carrier-RNA and 250 μL ethanol were added, incubated at room 
temperature and applied to the column. The column was centrifuged at 6,000 x g for 1 
minute, the membrane washed with 500 μL AW2 buffer, centrifuged at 6,000 x g for 1 
minute, washed with 500 μL ethanol and centrifuged at 20,000 x g for 10 minutes. For 
elution, 100 μL 80°C hot AVE was added, incubated at 4°C for 4 minutes and 
centrifuged at 20,000 x g for 1 minute. RNA was stored at -80°C until use. 
 
2.2.5.3. Isolation of viral RNA from urine 
 
Viral RNA was isolated with QIAamp Viral RNA Mini Kit (Qiagen) according to 
manufacturer’s instruction. In brief, 140 μL sample was mixed with 560 μL AVL 
containing 5.6 μg carrier RNA and incubated for 10 minutes at room temperature. 560 
μL ethanol was added to sample, applied to column and centrifuged at 6,000 x g for 1 
minute. The membrane was washed with 500 μL AW1, centrifuged at 6,000 x g for 1 
minute and 500 μL AW2 centrifuged at 20,000 x g for 3 minutes. Column was dried at 
full speed for 5 minutes and samples were eluted with 60 μL AVE heated to 80°C after 
incubation for 1 minute at 6,000 x g for 1 minute. Samples not used immediately were 
stored at -80°C for later use. 
 
2.2.5.4. Isolation of viral RNA from cell culture supernatant 
 
Viral RNA was isolated with NucleoSpin® RNA virus according to manufacturer’s 
instructions. In brief, 75 μL samples were mixed with 300 μL RAV1 and inactivated at 
70°C for 5 minutes. The sample was mixed with 300 μL ethanol, applied to column 
and centrifuged at 8,000 x g for 1 minute. The membrane was washed with 500 μL 
RAW and 600 μL RAV3 with a spin of 8,000 x g for 1 minute in between. Final wash 
was done with 200 μL RAV3, the membrane dried twice at 11,000 x g for 5 minutes 
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and RNA eluted with 60 μL 80°C RNase-free water after an incubation of 1 minute at 
11,000 x g for 1 minute.  
 
2.2.5.5. Isolation of total RNA from cells 
 
Total RNA was isolated from cells with NucleoSpin® RNA II according to 
manufactures instructions. In brief, cells were lysed in 350 μL RA1 containing 3.5 μL 
β-mercaptoethanol. Lysates was applied to filter columns and spined at 11,000 x g for 
1 minute. Binding conditions were adjusted by adding 350 μL 70% ethanol to the 
sample, mixture applied to column and spined at 11,000 x g for 30 seconds. 
Membranes were desalted with 350 μL MDP, centrifuged at 11,000 x g for 1 minute 
and DNA digested with 95 μL DNAse reaction mixture at room temperature for 15 
minutes. Membranes were then washed with 200 μL RA2 and 600 μL RA3 and 
centrifuged at 11,000 x g for 30 seconds in between. The final wash was done with 250 
μL RA3 at 11,000 x g for 2 minutes and membranes were dried at 11,000 x g for 4 
minutes. RNA was eluted in 60μL RNase free water at 80°C by centrifuging at 11,000 
x g for 1 minute. Samples were stored at -20°C until needed 
 
2.2.5.6. Agarose gel electrophoresis 
 
Electrophoretic analysis of DNAs on agarose gels was done to verify PCR 
amplification. Gel electrophoresis was done with 2% RotiAgarose GTQ in 1x TBE 
buffer containing 1.5 μL of 1% ethidium bromide per 50 mL agarose. 10 μL of PCR 
product was mixed with 6x loading dye, applied on gel and separated at 80-120 V. The 
size of DNA fragments was determined by using a 100 bp DNA ladder. After 
separation of DNA, the gel was analysed under UV light.  
 
2.2.5.7. Purification of PCR products 
 
PCR products were purified for further analysis with SeqLab purification kit. PCR 
product was mixed with 500 μL binding buffer, applied to column and centrifuged at 
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10,000 x g for 2 minutes. Elution buffer (20-50 μL) was applied, incubated for 5 
minutes and purified DNA eluted at 5,000 x g for 1 minute.  
 
2.2.5.8. Photometric determination of nucleic acid concentration 
 
Nucleic acid concentrations were determined using PeqLabs NanoDrop 2000c. As a 
blank, solvent of nucleic acid was used. For photometric determination, 1 μL of 
nucleic acid was measured three times and the mean value used as concentration.  
 
2.2.5.9. Sequencing of DNA 
 
Purified PCR product (2.2.5.7.) were sent to SeqLab Sequence Laboratories Göttingen 
for sequencing. Sequencing reaction contained 2 μL purified DNA, 1.43 μmol/L 
sequencing primer and 4 μL RNase free water. Sequence data was viewed with 
BioEdit 7.0.5.3 and sequence alignments were generated with DNASTER Lasergene 
7. 
 
2.2.5.10. Generation of in vitro transcript   
 
For the quantification of Kumasi rhabdovirus RNA an in vitro transcript was 
generated. The amplicon from a 893 bp fragment of the N-gene was purified according 
to 2.2.5.7. and cloned with TOPO® TA Cloning® kit (Invitrogen). The Ligation 
reaction contained 2 μL of amplicon, 0.5 μL salt-solution and 0.5 μL pCA TOPO TA 
cloning vector and was incubated for 30 minutes at room temperature, followed by 2 
minutes on ice. For transformation, 50 μL TOP 10 competent cells were added to the 
ligation reaction and incubated on ice for 25 minutes. Heat-shock was done for 30 
seconds at 42°C followed by 1 minute on ice and bacteria were thereafter incubated in 
250 μL SOC medium at 37°C for 1h. Transformed bacteria were plated on LB-Agar 
plates containing kanamycin and incubated at 37°C over night. Orientation of insert 
was tested with a colony PCR. Reaction mix contained 2.5 μL 10x Platinum Taq 
buffer, 200 nmol/L dNTP each, 2 mmol/L MgCl2, 19.4 μL RNA free water, 200 
nmol/L M13mod forward and BtRhabdoM17-rt reverse primer and half of bacteria 
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colony. Cycling conditions were 6 minutes at 95°C with 40 cycles of 15 seconds at 
05°C, 15 seconds at 58°C and 40 seconds at 72°C with a final elongation of 1 minute 
at 72°C. PCR products were analysed by gel electrophoresis (2.2.5.6). Clones with the 
correct orientation of insert were expanded in 1 mL LB-medium containing 
kanamycin at 37°C over night. Plasmid DNA was extracted with QIAprep Spin 
Miniprep-Kit (Qiagen) according to manufacturer’s instructions. In brief, overnight 
culture was centrifuged at 17,000 x g for 2 minutes and the pellet resuspended in 250 
μL P1-buffer. Suspension was carefully mixed with 250 μL P2-buffer followed by 350 
μL N3-buffer and cleared at 17,000 x g for 10 minutes. Supernatant was applied on 
QIAprep-column, spinned at 17,000 x g for 1 minute, washed with 500 μL PB-buffer 
and 750 μL PE-buffer with a spin of 17,000 x g for 1 minute followed and dried with 
an extra spin. Plasmid DNA was eluted in 50 μL EB-buffer after an incubation of 1 
minute at room temperature at 17,000 x g for 1 minute. Isolated DNA was serially 
diluted from 10-1 to 10-12 in RNase-free water containing 10 ng/μL carrier RNA and 
amplified with M13mod forward and reverse primers and 5 μL template as described 
above. The last detectable dilution was sequenced (2.2.5.9.) for confirmation and in 
vitro transcribed with MegaScript T7 ® kit (Invitrogen). The in vitro transcription mix 
contained dNTP 7.5 mmol/L each, 2 μL 10x reaction buffer, 2 μL enzyme mix, 4 μL 
RNase free water and 4 μL PCR product. The transcription mixture was incubated at 
37°C for 4h followed by a DNA digest with 1μL TurboDnase at 27°C for 30 minutes. 
The transcript was purified with the RNeasy kit (Qiagen) according to manufactors 
“clean-up” protocol and eluted in 50 μL RNase free water. RNA concentration was 
measured according to 2.2.5.8. and the copy number/μL calculated according to the 
following equation  
 
 
 x (6 x ) 
 
 
The transcriped was aliquoted and stored at -20°C until use.  
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2.2.6. Reverse transcription polymerase chain reaction 
 
Polymerase chain reaction (PCR) is generally used for exponential amplification of 
DNA fragments using a DNA polymerase and specific forward and reverse primers. 
In One-step reverse transcription (RT) PCR the same principle applies however, RNA 
is first transcribed into cDNA using a reverse transcriptase followed by amplification 
of the cDNA. The reaction is done in one tube, thereby minimizing the risk of 
contamination and simplifying the reaction setup.  
 
2.2.6.1. Genera specific hemi-nested RT- PCR for Paramyxoviridae 
 
Paramyxoviridae were detected with a genera specific hemi-nested RT PCR according 
to [101]. The assay covers the genera Respirovirus/Morbillivirus/Henipavirus, 
Avulavirus/Rubulavirus and the genus Pneumorvirus in three independent reactions. Full 
virus RNA extracts of Measles-, Mumps- and Human metapneumo virus were used as 
controls for the individual reactions. Reactions were done in 25 μL using the 
Invitrogen SuperscriptTM III OneStep RT-PCR kit with 12.5 μL 2x reaction buffer, 920 
nmol/L first round forward and reverse primer, 2.4 mmol/L MgSO4, 200 μmol/L 
dNTP each, 1 μL enzyme mix, 1 μg BSA, 10 units (U) RNAseOut (Invitrogen) and 5 
μL RNA template. First round amplification involved 1 minute at 60°C, 30 minutes at 
48°C, 2 minutes at 94°C followed by 45 cycles of 15 seconds at 94°C, 30 seconds at 
50°C and 30 seconds at 72°C followed by a final elongation time of 7 minutes at 72°C. 
The second round of PCR was done in 50 μL using 2 μL of first round PCR product, 
with 5 μL 10x Platinum Taq buffer (Invitrogen), 200 μmol/L dNTP each, 2.0 mmol/L 
MgCl2, 1 μmol/L second round forward and reverse primer, and 1 U Platinum Taq 
polymerase. Second round amplification was done for 3 minutes at 94°C with 45 
cycles of 15 seconds at 94°C, 30 seconds at 50°C and 30 seconds at 72°C with a final 
elongation of 7 minutes at 72°C. PCR products were analysed by gel electrophoresis 
(2.2.5.6.).  
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2.2.6.2. Kumasi rhabdovirus Real-time RT PCR  
 
Kumasi rhabdovirus RNA was detected and quantified by real-time RT PCR. The 
assay sensitivity was determined to be on the order of 90 copies per reaction by using a 
quantified in vitro transcript (2.2.5.10.). Reactions were done in 25 μL using the 
Invitrogen SuperscriptTM III OneStep RT-PCR kit with 12.5 μL 2x reaction buffer, 1.6 
mmol/L MgSO4, 200 μmol/L deoxynucleoside triphosphates (dNTP), 800 nmol/L 
forward and reverse primer, 280 nmol/L Kumasi rhabdovirus specific probe, 1μg 
bovine serum albumin (BSA), 0.8 μL RNA-free water, 1 μL enzyme mix and 5 μL 
RNA template. Reverse transcription was done at 55°C for 20 minutes, followed by 
initial denaturation at 95°C for 3 minutes and 45 cycles of 95°C for 15 seconds and 
58°C for 40 seconds, a final cooling round at 37°C for 2 minutes was included.  
2.2.6.3. Henipavirus real time RT-PCR 
 
A subset of spleen positive for the genus Henipa virus and the organs of the respective 
animals were quantified by real time RT-PCR. Depending on the primer combination 
minor changes were done in the protocol. The general reaction was done in 25 μL 
using the Invitrogen SuperscriptTM III OneStep RT-PCR kit with 12.5 μL 2x reaction 
buffer, 1.6 mmol/L MgSO4, 200 μmol/L deoxynucleoside triphosphates (dNTP), 800 
nmol/L forward and reverse primer, 280 nmol/L probe, 0.5 μg bovine serum albumin 
(BSA), 0.8 μL RNA-free water, 1 μL enzyme mix and 5 μL RNA template. Reverse 
transcription was done at 55°C for 20 minutes, followed by initial denaturation at 
95°C for 3 minutes and 45 cycles of 95°C for 15 seconds and 58°C for 40 seconds, a 
final cooling round at 37°C for 2 minutes was added. Viral concentration was 
calculated by extrapolation, assuming the minimum of detection is 10 viral RNA 
copies at a cycle threshold (CT) of 40.  
 
2.2.7. Phylogentic analyis 
2.2.7.1. Phylogenetic analysis KRV 
 
Reference sequences of Rhabdovirdiae were downloaded from GenBank (accession 
numbers are provided in Fig. 2) and protein coding sequences were extracted using 
Geneious 5.1 software [103]. Translated amino acid sequences were aligned using 
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MAFFT V7 [104]. Tree topologies were calculated with MEGA 5.2 [105] using the 
Maximum Likelihood algorithm with the complete deletion option and a 
WAG+G+I+F predicted to be the most suitable using the Model selection tool in 
MEGA 5.2. Bayesian phylogeny of dimarhabdoviruses was done with MrBayes V.3.1 
[106] also using the WAG amino acid substitution model with 1,000 parallel 
Maximum Likelihood bootstrap replicates. Trees were visualized in FigTree from the 
BEAST V1.7.4 package [107], Rabies virus was chosen as outgroup. 
 
2.2.7.2. Phylogenetic analysis Paramyxoviridae 
 
Reference sequences of Paramyxoviridae were downloaded from GenBank (accession 
numbers are provided in Fig. 4). Translated amino acid sequences were aligned using 
MAFFT V7 [104]. The alignment contained a 439 nucleotide (henipaviruses) and 169 
nucleotide (rubulaviruses) part of the L-gene. Bayesian phylogenetic trees of henipa- 
and rubulaviruses were done with MrBayes V.3.1 [106] using the WAG amino acid 
substitution model. Statistical support of grouping from Bayesian posterior 
probabilities contained 1,000 parallel Maximum Likelihood bootstrap replicates. 
Measles virus was chosen as outgroup for henipaviruses and Nipah virus as outgroup 
for rubulaviruses. For rubulaviruses, a monophyly prior was set on all members of the 
genus Rubulavirus to stabilize the phylogenetic reconstruction. Trees were visualized in 
FigTree from the BEAST V1.7.4 package [107]. The maximum internal amino acid 
distance among henipa- and rubulavirus clades was calculated in MEGA5.2 using the 
pairwise deletion option.  
 
2.2.8. Statistical analysis 
 
Cross tables were calculated using EpiInfo V7 (www.cdc.gov/epiinfo). Student’s T-test 
and ANOVA were calculated using IBM SPSS Statistics 22. Comparisons were considered 
significant when corrected 2-tailed p values were below 0.05. 
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3. Results 
3.1. Sampling 
 
In this study, E. helvum was sampled over three consecutive years (2009-2012) in 
Kumasi, Ghana for the purpose of detecting new and potential human pathogens, that 
could emerge from a bat reservoir, and observe them on a longitudinal base. E. helvum 
is a migratory bat and resides in Kumasi mainly from October to April. Therefore, the 
sampling was conducted during these months, with an exception of the years 2009 and 
2011, where additional samples were available in June also. Occasionally, the colony 
left town and the intended number of 12 animals per week was not sampled. For 
December 2009 and January 2012, no samples were available for the same reason. In 
total, 630 E. helvum were captured and sacrificed during the sampling time. For each 
individual bat, the spleen, liver, kidney, brain, gut and intestine were sampled and 
aliquots of each sample were shock-frozen and formalin embedded. Additionally, 
urine samples from the same colony were collected. Of 155 urine samples, 17 were 
pooled samples and contained 10 drops of urine each. Human serum samples were 
obtained from 45 individuals working at and/or living in the zoological gardens of 
Kumasi or handling bats on a regular basis. Furthermore, 103 samples from patients of 
the Komfo Anokye Teaching Hospital in Kumasi were obtained from a co-operation 
partner and included in the study. Livestock serum was sampled from 106 cattle, 105 
sheep, 124 goat and 107 swine. Samples were collected from farms and abattoirs in 
and around Kumasi. 
 
3.2. Detection of Paramyxoviridae in E. helvum 
 
The spleen of 630 E. helvum from Kumasi, Ghana, sampled during the years 2009 to 
2012 were tested by three hemi-nested RT-PCR [101] assays designed to allow 
detection of all Paramyxoviridae genera. The spleen was used for screening because 
several virus-positive animals had shown the highest virus concentrations in the 
spleen. Additionally, 155 urine samples from the same colony were tested. 
Henipaviruses were detected in 109 (17.3%) animals while rubulaviruses were detected  
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Table 1: Detection rate of Paramyxoviridae in E. helvum. The samples were collected 
over three consecutive years in Kumasi, Ghana. The table below shows the total 
number of samples tested, the number and percentage of spleen tested positive for the 
genera Henipa- and Rubulavirus. Months in which no positive sample was detected are 
marked with minus. 
 
Month Year Tested spleens Henipavirus % Rubulavirus % 
March  2009 23 7 30.4 6 26.1 
June  2009 20 3 15 3 15 
November  2009 60 17 28.3 4 6.7 
January  2010 13 - - - - 
February  2010 18 1 5.6 - - 
March  2010 37 4 10.8 9 24.3 
April  2010 6 - - 1 16.7 
October  2010 20 5 25 2 10 
November  2010 40 5 12.5 - - 
December  2010 5 - 0 - - 
January  2011 22 1 4.6 - - 
February  2011 17 3 17.6 2 11.7 
March  2011 48 8 16.7 9 18.7 
April  2011 32 10 31.3 13 40.6 
Mai  2011 22 4 18.2 2 9.1 
June  2011 10 1 10 1 10 
October  2011 43 4 9.3 3 6.9 
November  2011 48 8 16.7 6 12.5 
December  2011 49 5 10.2 4 8.2 
February  2012 46 16 34.8 8 17.4 
March  2012 36 3 8.3 - - 
April  2012 15 4 26.7 - - 
Total  630 109 17.3 73 11.6 
 
 
in 73 (11.6%) animals. In none of the samples pneumoviruses were detected. This data 
set included samples (2009 to 2010), already published, in which 31 henipaviruses and 
20 rubulaviruses were detected [16]. Additional 71 henipaviruses and 84 rubulaviruses 
were found in samples from 2010 to 2012.  
 
3.3. Phylogeny of Paramyxoviridae in E. helvum and other African 
fruit bats 
 
Phylogenetic trees were constructed which contained all Paramyxoviridae sequences 
from the E. helvum colony in Kumasi and all published henipa- and rubulaviruses from 
African fruit bats [16, 108, 109]. The sample set covered the countries Ghana, Gabon, 
Republic of Congo, Central African Republic and Democratic Republic of the Congo. 
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In a bayesian analysis, henipaviruses clustered in eleven well-supported clades (Fig. 
4A). In agreement with the phylogeny, the clades could be separated by a 30% amino 
acid distance threshold (Fig. 4C), seven of which contained viruses from E. helvum of 
Kumasi. Two other clades contained viruses only from other fruit bats (Myonyteris, 
Epomophorus, Hypsignathus, Rousettus, Megaloglossus). Another two clades contained the 
Australian Hendra- and Nipahvirus and Cedarvirus, respectively. Viruses present in E 
.helvum from Kumasi were also found in E. helvum from the five different sampling 
countries.  
 
Rubulaviruses from African fruit bats clustered in ten clades in a bayesian analysis 
(Fig. 4B). In accordance with phylogeny, these clades could be separated by a 31% 
amino acid detection threshold. Eight of these clades contained viruses of E. helvum 
from Kumasi. Achimota virus 2 (AchV2) was recently isolated from E. helvum in 
Accra, Ghana and formed a single clade. This virus was not detected in E. helvum from 
Kumasi although it is assumed that the colony in Accra and Kumasi belongs to the 
same population of bats. Tuhoko virus 2 (TukV2) was detected in a Chinese Rousettus 
bat and also clustered individually in the present phylogenetic tree. Rubulaviruses 
detected in E. helvum from Kumasi were also detected in all five sampling countries. 
Seven of theses rubulaviruses were not published previously.  
 
The sampling of E. helvum from Kumasi was done during three consecutive years 
(2009 to 2012). All but one henipavirus clade detected in E. helvum bats were present 
in the Kumasi colony in all three sampling years. For rubulaviruses, all clades which 
contained viruses from E. helvum were represented in Kumasi apart from AchV2.  
 
The viral concentrations of henipaviruses were determined for 22 positive animals 
with real-time RT-PCR. Virus concentrations in the spleen ranged from 105 to 108 viral 
RNA copy numbers per gram tissue (Fig. 5). The RNA concentrations were 
comparable over the years 2009 to 2011 to a mean of 106.51 viral RNA copy numbers 
per gram tissue. Viral RNA was also detected in the liver, kidney, lung, intestine and 
serum, but the highest concentrations were in the spleen (Fig. 5 and Tab. 2). 
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Figure 4: Bayesian phylogeny and maximum internal amino acid distance of the L-
gene of bat paramyxoviruses. (A) Henipaviruses detected in African fruit bats (B) 
Rubulaviruses detected in African fruit bats.  The statistical support for posterior are 
not shown for rubulavirus clades because these clades were identified in Neighbour-
Joining phylogeny. Circles represent sampling area (RCA = Central African Republic, 
DRC = Democratic Republic of the Congo, Congo = Republic of the Congo), squares 
indicate fruit bat species. Viruses detected in E.helvum from Kumasi are highlighted 
with red branches. Numbers represent individual clades. Branch lengths are drawn to 
scale. Statistical support of grouping from Bayesian posterior probabilities and 1,000 
parallel Maximum Likelihood bootstrap replicates is indicated at deep node points. 
Scale bars correspond to genetic distance. Internal amino acid divergence of the L-
fragment is shown for henipavirus clades (C) and rubulavirus clades (D). Maximum 
amino acid sequence distance was calculated with MEGA5.2 using the pairwise 
deletion option. Clades which contained only one sequence were excluded for 
graphical reasons. 
. 
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Figure 5: Henipavirus RNA concentrations in solid organs of E. helvum bats. (A) 
Virus concentrations given in log10 RNA copies per mL of serum, or per gram of 
tissue scaled on the y-axis, were plotted for each bat organ tested. All bats were 
sampled between 2009-2010 from one large colony located in Kumasi, Ghana. To 
facilitate evaluation of virus concentrations, organs were structured according to 
means, which were connected with a solid line for graphical reasons only. Bars below 
the limit of detection of the real time RT-PCR assay, used for quantification, represent 
negative test results. Colours represent individual bats given on the right of the figure. 
(B) Viral concentration of paramyxoviruses in the spleen of individual bats, shown in 
A, but are represented over the sampling period 2009 to 2010.  
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Table 2: Henipavirus viral RNA concentrations in bat solid organs and serum. Bats 
were sampled between 2009 and 2011. Virus concentrations are given in log10 RNA 
copies per gram tissue or millilitre serum. Samples in which viral concentration was 
below the detection limit are marked with minus. 
 
  Log10 viral RNA copies per g tissue / mL serum 
Animal 
ID 
Spleen Liver Kidney Lung Intestine Serum Brain 
Gh74 6.32 4.18 - - - - - 
Gh51 6.02 - - - - - - 
M-17 5.55 - - - - - - 
F-7 5.52 3.18 3.18 4.16 3.91 - - 
Gh2 5.48 - - - - - - 
Gh48 5.14 - - - - - - 
Gh84 5.02 3.48 - 4.24 - - - 
M-1 4.89 - - - - - - 
Gh28 4.80 - - - - - - 
J-9 4.79 3.31 3.31 - - - - 
F-2 4.61 - - - - - - 
M-43 4.47 - 3.31 - - - - 
Gh95 4.45 3.31 - - - - - 
Gh91 4.31 - - - - - - 
Gh8 4.28 - - n.a. n.a. - n.a. 
Gh55 4.14 - - - - - - 
Gh69 4.02 - - - - - - 
Gh94 4.00 - - - - - - 
Gh10 3.82 - - - n.a. 2.15 - 
Gh93 3.67 - - - - - - 
GH65 3.60 - - - - - - 
GH90 - - 3.31 - - - - 
n.a. = no sample available 
 
 
3.4. Virus isolation 
 
Virus isolation from E. helvum spleen and urine samples was approached in two ways: 
as undirected virus isolation, without knowing the virological background of the 
sample, and as directed virus isolation with samples positive for the genus Henipavirus. 
No virus isolate was obtained from directed virus isolation from neither spleen nor 
urine samples. From ten spleens used in undirected virus isolation, a virus was isolated 
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Figure 6: Cytopathic effect and electron microscopic (EM) picture of KRV. VeroE6 
cells were infected with KRV with an MOI of 0.001. (A) Cytopathic effect of KRV 
four days post-infection. VeroE6 cells were infected with an MOI of 0.001 after four 
days cells detached and rounded. (B) Mock control: VeroE6 cells monolayer after four 
days. (C) EM picture of KRV. The supernatant of KRV infected VeroE6 cells was 
ultracentrifuged on a saccharose cushion and the pellet was used for analysis. The bar 
in the EM picture represents 100 nm. The picture was courtesy of A. Kurth. 
 
 
from one spleen collected in March 2010 (M35). Four days post infection (dpi), a CPE 
characterized by rounding and detaching of cells, was seen on EidNi/EidLu cells (Fig. 
6A). The supernatant of infected cells revealed particles with the characteristic bullet 
shape of rhabdoviruses by electron microscopy (Fig. 6C). The virus was named 
Kumasi rhabdovirus (KRV) after the town of its isolation. 
 
3.5. Virus characterisation 
 
The growth of KRV on primate, human and bat cell lines was characterized. Virus 
concentration was determined by real-time RT-PCR and plaque assay and expressed 
as log10 viral RNA copies/mL and log10 pfu/mL. African green monkey kidney 
interferon incompetent (VeroFM) and competent (Ma104) cell lines, human lung 
carcinoma cell line (A549) and E. helvum kidney (EidNi) and lung (EidLu) cell lines 
were used. KRV could be propagated in all tested cell lines with similar growth 
kinetics (Fig. 7). KRV reached the growth plateau between 48 and 72 h with the 
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Figure 7: Growth kinetic of KRV on mammalian cell lines. KRV was inoculated 
with a MOI of 0.001 on African green monkey kidney interferon incompetent 
(VeroFM) and competent (Ma104) cell lines, human lung carcinoma cell line (A549) 
and E. helvum kidney (EidNi) and lung (EidLu) cell line. Virus concentrations are 
given in log 10 RNA copies/mL (A) and log 10 pfu/mL (B). KRV enters and 
replicates in all five cell lines. Highest titres were reached in primate cell lines, 
followed by the human cell line and bat cell lines.  
 
 
exception of VeroFM cells in which the plateau was reached after 96 h. Virus 
concentration varied between species. On primate cell lines, the highest titers of KRV 
were obtained on interferon incompetent cells. In comparison, growth on human cell 
lines was reduced to 1.8 - 42.4 fold. The lowest titres were seen in bat cell lines with 
better replication on kidney cell cultures, compared to lung cell cultures.  
 
3.6. Detection of KRV 
 
Screening for the presence of KRV in E. helvum organs was done with specific real-
time RT-PCR. The spleen was used because several virus-positive animals had shown 
the highest virus concentrations in the spleen. E. helvum spleen from three consecutive 
seasons (2009-2011) were tested. KRV was detected in 25 (5.1%) of 487 spleens. Virus 
concentration ranged from 104 to 108 viral RNA copy numbers per gram tissue. For all 
positive animals, viral RNA concentrations in the lung, brain, liver, kidney, gut, serum 
and intestine were determined with real-time RT-PCR (Fig. 8 and Tab. 3). The 
predominance of virus concentrations in the spleen was confirmed. In five animals, 
viral RNA was also detected in other organs.  
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Figure 8: KRV RNA concentrations in solid organs of E. helvum bats. (A) Virus 
concentrations given in log10 RNA copies per mL of serum, or per gram of tissue 
scaled on the y-axis, were plotted for each bat organ tested. All bats were sampled 
between 2009-2011 from one large colony located in Kumasi, Ghana. To facilitate the 
evaluation of virus concentrations, organs were structured according to means, which 
were connected with a solid line for graphical reasons only. Bars below the limit of 
detection of the real time RT-PCR assay used for quantification represent negative test 
results. Colours represent individual bats given on the right of the figure. (B) Viral 
concentration of KRV in the spleen of individual bats, shown in A, but are represented 
over the sampling period 2009 to 2011.  
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Table 3: KRV RNA concentrations in solid organs of E. helvum bats. Bats were 
sampled between 2009 and 2011. Virus concentrations are given in log10 RNA copies 
per gram tissue or millilitre serum. Samples in which viral concentration was below 
the detection limit are marked with minus.  
 
 
 Log10 viral RNA copies per g tissue / mL serum 
Animal 
ID 
Spleen Lung Brain Liver Kidney Gut Serum Intestine 
M36 8.85 6.70 5.36 5.44 5.72 5.28 5.22 5.71 
M15 8.53 - - - - - - - 
M30 8.52 8.62 6.33 7.72 7.15 6.91 7.14 6.80 
Gh203 7.86 - - - - - - - 
Gh229 7.31 - - - - - - - 
GH170 7.15 - - - - - - - 
Gh196 6.99 - - - - - - - 
91 6.96 5.46 4.93 5.44 5.04 - - - 
B054 6.95 6.35 5.68 6.05 5.39 5.72 5.73 - 
Gh211 6.89 - - - - - n.a. - 
M35 6.55 - 4.81 - - 4.51 - - 
Gh213 6.47 - - - - - - - 
Gh299 6.44 - - - - - n.a. - 
Gh218 6.25 - - - - - n.a. - 
B052 6.12 - - - - - - - 
M26 6.03 - - - - - - - 
Gh298 5.66 - - - - - n.a. - 
83 5.60 - - - - - - - 
M37 5.52 - - - - - - n.a. 
M46 5.42 - - - - - - - 
Gh234 5.29 - - - - - - - 
Gh238 5.29 - - - - - - - 
M32 5.16 - - - - - - - 
Gh210 5.04 - - - - - - - 
M14 4.26 - - - - - - - 
n.a. = no sample available 
 
 
Viral concentrations in the spleen were comparable over the sampling months and 
years to a mean concentration of 106.44 viral RNA copies per gram tissue (Fig. 8 and 
Tab.3). The detection rate varied in the sampling years but no significant difference in 
seasons (p = 0.72) or year were observed (p = 0.73) (Tab. 5). KRV was detected in the 
months of March, April, May, October and November, but not in January, February, 
June and December. There were no samples available for the months of July, August 
and September, due to migration of the colony. The detection rate of KRV was 
significantly higher in juveniles compared to adults (χ2 = 4.06, p = 0.04). 
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Due to the known tropism of some rhabdoviruses for the central nervous system, 630 
brains were separately screened for KRV by RT-PCR, irrespective of the testing 
outcome of spleen samples. No additional positive brain samples were found. 
 
As it is known that many rhabdoviruses are transmitted by and maintained in 
arthropod vectors, 1240 female mosquitoes (Aedes ssp., Culex ssp., Eretmapodites ssp., 
Lutzia ssp., Mansonia ssp., Toxorhynchites ssp.) from close proximity of the E. helvum 
colony sampled in 2011, were tested in real-time RT-PCR. None of the tested 
mosquitoes was positive for KRV viral RNA.  
 
3.7. Phylogenetic classification of KRV 
 
The phylogenetic classification of Rhabdoviridae is classically done using the 
nucleoprotein (N) gene. In figure 9 a phylogenetic tree of the N-gene, including all 
genera of Rhabdoviridae, is shown. Because highest sequence conservation and better 
support were obtained when the L-protein (L) gene was used, phylogenetic analysis of 
KRV was done using the L-gene. 
 
 
 
 
 
 
Figure 9: Phylogentic relationship of the N and L protein of KRV (red). Analyses 
were performed using the Maximum likelihood algorithm. Tree settings are described 
in methods. Branch lengths are drawn to scale. (A) Phylogenetic tree of the N protein 
including representatives of all Rhabdoviridae genera. (B) Phylogenetic relation of the L 
protein of members of the dimarhabdovirus supergroup.  
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Figure 10A shows a Maximum likelihood tree of the L-gene including all 
Rhabdoviridae genera. KRV was classified in the supergroup of dimarhabdovirses. It 
clustered in an independent, deeply-rooted branch monophyletic to Nishimuro virus. 
This relationship was confirmed in a tree of the N-gene (Fig. 9A).  
 
The dimarhabdovirus supergroup comprises viruses with only short sequence 
information available for the L-gene. Therefore, a Bayesian analysis of 
dimarhabdoviruses, using the N-gene, was done. KRV clustered in a well supported 
clade, monophyletic with Mount Elgon bat virus (MEBV), Oita rhabdovirus (OIRV) 
and Kern Canyon virus (KCV) (Fig. 10B). This relation was supported with high 
amino acid identities in the L-gene (71.3 – 88.9) and the N-gene (41.2 – 65) (Tab. 4). 
Nishimuro virus formed a sister group to this clade. 
 
3.8. Genome characterization of KRV 
 
The complete 11,075 nt KRV genome exhibited typical rhabdovirus organization 
consisting of 3’- and 5’ terminal non-coding regions (approximately 70 nt and 28 nt, 
respectively) and five genes, each bound by putative transcriptional regulatory 
sequences. As shown for other rhabdoviruses the transcription inititiation sequence 
(AACGAGA) and transcription termination sequence (CAUG[A]7) are highly 
conserved with exception of gene 2 whose termination sequence is CUGG[A]6. Gene 
1 (N) encodes a 427-aa protein (47.95 kDa), gene 3 (M) encodes a 207-aa protein 
(23.81 kDa), gene 4 (G) encodes a 551-aa protein (62.02 kDa), and gene 5 (L) encodes 
a 2122-aa protein (241.55 kDa). No continuous orf was found in gene 2. However, 
three smaller orfs were predicted coding for three hypothetical proteins with 72 aa (orf 
2), 22 aa (orf 3), and 57 aa (orf 4). 
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Figure 10: Phylogentic classification and genome organisation of KRV. (A) 
Maximum likelihood analysis of the L gene including representatives of all 
Rhabdoviridae genera and KRV (red). (B) Bayesian tree of the N-genes of the 
dimarhabdovirus supergroup. The WAG amino acid substitution model was used. 
The statistical support of grouping from Bayesian posterior probabilities and 1,000 
parallel Maximum Likelihood bootstrap replicates are indicated at deep node points. 
Scale bars correspond to genetic distance. (C) Genome organization of KRV. Grey 
arrows represent suggested open reading frames (orf) for putative nucleocapsid (N), 
matrix (M), glyco (G) and large (L) protein along the KRV genome. Also shown are 
three hypothetical orfs that were predicted in the genome region between N and M. 
Numbers below orf symbols represent genome positions of the respective orf. BASV 
(JX297815) Bas-Congo virus, BEFV (NC002526) Bovine ephemeral fever virus, 
CHPV (NC020805) Chandipura virus, SIGMAV (NC013135) Drosophila 
melanogaster sigma virus, DURV (FJ952155) Durham virus, IHNV (NC001652) 
Infectious hematopoietic necrosis virus, KCV (DQ457101) Kern Canyon virus, KOTV 
(NC017714) Kotonkan virus, KRV (KJ179955) Kumasi rhabdovirus, LBV 
(NC020807) Lagos bat virus, LNYV (NC007642) Lettuce necrotic yellows virus, 
MSPV (KC412247) Malpais spring virus, MARAV (HQ660076) Maraba virus, MEBV 
(DQ457103) Mount Elgon bat virus, MOUV (FJ985749) Moussa virus, NISV 
(AB609604) Nishimuro virus, NGAV (NC013955) Ngaingan virus, OIRV 
(AB116386) Oita rhabdovirus, PRV (NC020803) Perch rhabdovirus, PERV 
(HM566195) Perinet virus, PFRV (FJ872827) Pike fry virus, PYDV (NC016136) 
Potato yellow dwarf virus, RABV (NC001542) Rabies virus, (DQ457104) 
Rochambeau virus, (DQ457102) Sandjimba virus, TRV (KC113517L) Tench virus, 
TIBV (NC020804) Tibrogargan virus, TUPV (NC007020) Tupaia virus, VSINV 
(NC001560) Vesicular stomatitis Indiana virus, WONV (NC011639) Wongabel virus.   
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Table 4: Amino acid identity of individual protein sequences of the 
dimarhabdovirus supergroup. Identities are expressed in percent and were calculated 
as pairwise deletion using MEGA 5.1. Sequence information was not available for 
every gene of each virus.  
 
Pairwise amino acid identities 
L gene KRV MEBV ORV KCV NISV VSINV CHPV BEFV KOTV PFRV PRV TUPV WONV 
KRV              
MEBV* 86.1             
ORV 88.9 83.3            
KCV** 71.3 83.3 83.3           
NISV 47.6 86.1 80.6 74.3          
VSINV 43.7 72.2 66.7 67.6 44.9         
CHPV 43.7 66.7 61.1 66.2 43.7 59.7        
BEFV 38.1 63.9 61.1 61.0 40.5 41.8 41.9       
KOTV 40.9 61.1 61.1 63.2 41.9 44.7 43.2 50.6      
PFRV 43.4 77.8 66.7 69.9 42.9 52.8 52.5 42.1 44.0     
PRV 41.7 66.7 69.4 71.3 44.0 45.5 45.7 41.0 41.7 46.9    
TUPV 39.7 55.6 52.8 63.2 41.2 41.8 41.5 38.5 39.0 40.5 40.3   
WONV 38.9 61.1 58.3 61.0 40.8 41.4 42.1 42.3 43.8 42.8 41.8 41.3   
*identity over 281 amino acid residues **identity over 316 amino acid residues     
              
N gene KRV MEBV ORV KCV NISV VSINV CHPV BEFV KOTV PFRV PRV TUPV WONV 
KRV              
MEBV* 65.0             
ORV* 59.2 63.1            
KCV** 41.2 42.3 42.5           
NISV 39.7 44.0 36.7 42.2          
VSINV 27.9 31.4 30.3 30.4 30.7         
CHPV 27.6 27.9 28.1 30.7 30.8 51.0        
BEFV 29.4 32.3 29.3 32.1 31.7 30.6 30.0       
KOTV 30.1 32.6 29.3 35.9 34.1 32.0 31.3 51.8      
PFRV 32.1 33.7 30.5 31.4 29.9 52.8 45.6 30.7 29.2     
PRV 28.8 33.8 28.5 34.0 30.7 32.3 31.1 30.3 32.0 32.8    
TUPV 30.8 36.6 32.5 34.6 37.2 30.8 29.8 31.4 35.4 32.2 28.7   
WONV 28.7 30.1 30.0 31.4 32.3 30.3 29.8 35.8 38.1 28.8 27.3 32.6   
*identity over 36 amino acid residues **identity over 136 amino acid residues     
              
G gene KRV NISV VSINV CHPV BEFV KOTV PFRV PRV TUPV WONV    
KRV              
NISV 25.7             
VSINV 21.3 22.0            
CHPV 21.9 24.1 40.6           
BEFV 20.5 19.0 18.8 20.2          
KOTV 19.5 17.9 22.2 19.8 31.8         
PFRV 20.2 19.8 33.6 31.7 18.8 19.5        
PRV 20.2 21.5 23.3 23.7 17.9 19.1 23.4       
TUPV 20.2 21.4 19.3 20.6 15.6 16.9 19.6 18.5      
WONV 23.2 21.3 20.5 22.8 21.9 22.4 20.8 22.0 18.6      
              
M gene KRV NISV VSINV CHPV BEFV KOTV PFRV PRV TUPV WONV    
KRV              
NISV 32.0             
VSINV 10.2 17.7            
CHPV 11.9 18.2 29.4           
BEFV 23.7 24.1 12.9 10.6          
KOTV 22.1 24.0 11.9 13.4 41.0         
PFRV 12.8 15.9 32.0 23.4 14.8 15.2        
PRV 17.2 19.5 16.3 13.0 18.9 21.1 15.5       
TUPV 15.8 15.9 10.1 12.5 16.1 16.5 9.8 16.3      
WONV 18.3 19.3 11.2 13.1 21.2 25.6 14.0 20.1 10.9      
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3.9. Seroprevalence of KRV 
3.9.10. E. helvum 
 
The overall prevalence of KRV in the bat population was investigated by antibody 
detection assays. Of 349 E. helvum sera, pre-screened with an in-house ELISA 182 
(52.1%) had OD values above threshold (data not shown). The samples were 
confirmed with IFA on slides containing virus infected cells. Additional 127 serum 
samples were tested only with IFA. Representative pictures of IFA of positive and 
negative sera are shown in Fig. 11. Antibodies against KRV were detected in 55 
(11.5%) E. helvum serum samples. Positive samples were confirmed with PRNT. 
Neutralizing antibodies were detected in 33 sera (6.4%) in the range of 1:360 to 1:10. 
There was no significant difference in gender (χ2 = 1.3, p = 0.26) or age (χ2 = 0.03, p = 
0.87) distribution. In 2010, 18 (13.5%) animals had neutralizing antibodies compared 
to 2009, 4 (3.9%) and 2011, 11 (4.8%) (Tab. 5).  
 
3.9.10. Livestock 
 
Cross species transmission of KRV was tested for cattle, sheep, goat and swine from 
Kumasi and the surrounding with IFA. None of 106 cattle, 105 sheep, and 124 goat 
sera reacted with KRV. Out of 107 swine sera, 27 (28.9%) reacted with KRV in IFA. 
Five of these serum samples (5.4%) were confirmed with PRNT. However, 
neutralizing activity in all cases was at the limit of titration of the assay, yielding 50% 
plaque reduction at dilutions equal to 1:10. Representative pictures of IFA for positive 
and negative swine sera are shown in Fig. 11. 
 
3.9.11. Human 
 
Transmission of KRV to humans was tested for 163 samples with IFA. Samples 
originated from inhabitants of Kumasi with 45 serum samples from people living or  
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Figure 11: Serological analysis of bat, livestock and human sera for antibodies to 
KRV with specific indirect immunofluorescence assay. Vero FM cells infected with 
KRV were mixed with uninfected cells (1:1) and spotted on glass slides. Sera were 
diluted 1:40. Examples of sero positive and negative E. helvum, swine and human sera 
are shown here. Detection was done with goat anti-bat immunoglobulin (Ig), followed 
by donkey anti-goat Ig labeled with cyanine 2 (Cy2), goat-anti-swine Ig labelled with 
Cy2, goat-anti-human Ig labelled with Cy2, respectively. All positive samples had 
neutralizing antibodies in a 50% plaque-reduction assay. The bar represents 50 μm.   
 
 
 
 
working in close proximity to the E. helvum colony, and 118 samples from patients of 
the Komfo Anokye Teaching Hospital (KATH) which were provided by a co-
operation partner. Six sera showed reactivity in IFA. Five of these samples originated 
from workers of the Zoological gardens of Kumasi, but none of them had neutralizing 
antibodies against KRV. One patient sample had neutralizing antibodies with a titre of 
1:20. Positive and negative IFA pictures are presented in Fig. 11. 
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Table 5: Detection rate and seroprevalence of E. helvum for KRV. Samples were 
collected over three consecutive years in Kumasi, Ghana. The total numbers of 
samples tested for KRV are shown. The number and percentage of spleen tested 
positive with specific real time RT-PCR and the number and percentage of sera with 
neutralizing antibodies. Months in which no sample was positive are marked with 
minus. 
 
Month Year 
Total number 
spleen/sera 
Viral RNA % 
Neutralizing 
antibodies 
% 
January 2009 6/0 - - n.a.  
March 2009 16/20 - - 3 15 
June 2009 19/18 - - 1 5.6 
November 2009 55/56 1 1.8 2 3.6 
January 2010 12/11 - - 2 18.2 
February 2010 17/16 - - 1 6.3 
March 2010 33/37 8 24.2 4 10.8 
April 2010 4/6 1 25 1 16.7 
October 2010 40/38 - - 7 18.4 
November 2010 18/17 3 16.7 1 11.8 
December 2010 5/11 - - 1 9.1 
January 2011 18/12 - - - - 
February 2011 16/17 - - 2 11.8 
March 2011 44/41 1 2.3 3 4.9 
April 2011 32/32 6 18.8 2 6.3 
May 2011 22/17 3 13.6 2 11.8 
June 2011 10/4 - - 1 25 
October 2011 37/42 2 5.4 - - 
November 2011 48/46 - - - - 
December 2011 37/35 - - - - 
Total  487/467 25 5.1 33 6.4 
n.a.= sample not available 
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4. Discussion 
4.1. Virus diversity and potential viral origin 
 
The potential of bats to act as sources or reservoirs of emerging viruses is a complex 
problem amenable to analysis on various levels of investigation. Important aspects 
include ecological factors such as virus diversity and abundance, epidemiological 
factors such as the opportunities for interspecies contact, as well as virological 
parameters such as replication level and population immunity. In this work, two 
aspects were highlighted and investigated, including virus diversity in a fruit bat 
colony and the transmission of bat-derived viruses to humans and livestock. Fruit bats 
harbour a variety of virus families, wherein this study focused on members of the 
families Paramyxoviridae and Rhabdoviridae [41-43].  
 
Within the family Paramyxoviridae most interesting findings were obtained for the 
genera Henipa- and Rubulavirus. Members of these genera cause relevant infectious 
diseases in animals and humans (e.g. Rinderpest virus, Peste-des-petits-ruminants 
virus, Measles virus and Mumps virus). Our group has recently presented fundamental 
data linking the evolutionary provenance of all of those viruses to bats [16]. 
Additionally, some of the known fruit bat specific henipa- and rubulaviruses are 
known to cause recurring outbreaks in animals and humans making them fulfil the 
definition of zoonotic agents, such as Henda-, Nipah and Menangle virus [64, 76, 95]. 
 
Theoretically, the complete diversity of viruses in our samples could have been 
captured by deep sequencing. However, this method is still cost-intensive and 
currently does not feature the sensitivity necessary for testing complex samples such as 
organ biopsies. Also less complex samples such as serum or urine will not yield any 
results if the viral load is low. For this reason a hemi-nested RT-PCR was chosen as 
the main tool to test for novel paramyxoviruses in this study. The disadvantage of RT-
PCR methods is an amplification bias caused by the choice of primers. Expectably, 
more known viruses will be detected in comparison to novel viruses. To compensate at 
least partly for primer-dependent bias, a combination of three different hemi-nested 
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RT-PCR assays were applied, which were each designed so as to provide optimized 
specificity of one of the three genera Henipavirus, Rubulavirus, and Morbillivirus. These 
assays were known for their sensitivity, covered a broad range and were already 
successfully used for the detection of novel viruses [37, 108]. Furthermore, virus 
isolation was attempted for the detection of novel paramyxoviruses but remained 
unsuccessful. The isolation of unknown viruses from wild-life is challenging as no 
standard procedures can be applied. Successful virus isolation depends on a variety of 
factors such as the choice of cell culture systems, the concentration of virus input, 
conditions for maintenance of cell cultures, as well as the use of additives such as 
serum or growth hormones. Despite the availability of E. helvum cell cultures, 
knowledge of the other factors was lacking, posing challenges in the interpretation of 
negative results.    
 
In previous studies, paramyxoviruses have been detected in faeces, urine and the 
spleen of bats [16, 37, 108]. Urine and faeces do not involve invasive sampling and 
enable the collection of large amounts of samples. But urine and droppings are 
collected from a plastic foil which is placed under a roosting tree, and it is therefore 
not possible to assign samples to individual animals. Multiple-time sampling of 
individuals as well as some limited extent of cross-contamination between samples can 
therefore not be excluded. Working with organ samples can circumvent this problem 
but it involves killing of animals, limiting the number of samples that can be taken. I 
have followed a sampling design in which only few animals per visit had to be 
sacrificed while care was taken not to disturb the colony, with regular monitoring of 
signs of disturbance such as displacement of individual sub-groups to another known 
nearby roost in the same city. All organs from a subsample of sacrificed animals were 
initially tested quantitatively for henipaviruses, confirming the expectation that highest 
virus concentrations should be detectable in the spleen. In the remaining investigation, 
testing was then focused on spleen samples. Along with the targeted invasive 
sampling, non-invasive faecal and urine samples were taken from the colony during 
each visit. I believe this approach provides an overview of the diversity of viruses by 
collecting many non-invasive samples, and enables clear insight into detection rates by 
providing access to organs from individual animals.   
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Another way to improve the quality of my sample was to include diverse sources of 
sequence data. In my phylogenetic analyses, sequences from this study were 
supplemented by sequences from six different African fruit bat species sampled in five 
different African countries during own previous studies, as well as a number of 
published datasets [16, 37, 108, 109]. These collated data contain the largest overview 
on henipa- and rubulavirus genetic diversity possible at this time point.   
 
An immense new diversity of henipa- and rubulaviruses in Ghanaian fruit bats was 
detected in this study. Overall, the diversity of viruses remained constant over the 
three years of my observation. Remarkably, nearly the complete diversity of henipa- 
and rubulaviruses was represented in a single E. helvum colony from Kumasi, 
indicating that the viruses may be shared among fruit bats in Africa during annual 
migrations. There are currently no data available for the diversity of paramyxoviruses 
in other E. helvum colonies, making it impossible to say whether this colony is unique 
among others. However, the data suggest a remarkably high virus diversity in E. 
helvum in general. The reasons are unclear and it would be interesting to investigate 
the virus diversity from isolated colonies and compare the results with the diversity 
detected in this study [38].  
 
E. helvum is a migratory species which crosses large geographic distances (> 2000 km) 
during its annual migration [22]. Spatiotemporal overlap and social mixing of colonies 
might promote virus exchange. Accordingly, species with none or a small migratory 
range would exhibit lower virus diversity. In my data the virus diversity within the 
genus Rubulavirus was evenly distributed across bat species, indicating that the sample 
was large enough to display virus diversity up to a level of saturation (it was shown in 
a recent study that only a certain number of samples is necessary to detect the 
proximate virus diversity of a given species [110]). Interestingly, in the henipavirus 
phylogeny viral diversity was far larger in E. helvum than in any other species, 
supporting the idea of migratory behaviour to potentially foster the acquisition of a 
large range of viruses.  
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On the contrary, population size and density exert evolutionary pressure on parasites 
[111] and thus could as well influence the evolution of virus diversity. E. helvum forms 
huge colonies with up to 1 million animals while most other African fruit bats roost in 
smaller groups or individually. Rousettus is the only other species known to form social 
groups of considerable size, but these will typically not exceed 50,000 individuals 
[112]. Social groups can be dense, as Rousettus roosts in caves. However, if population 
density is the main factor driving virus diversity, the rate of henipavirus and 
rubulavirus diversity should have been similar in Rousettus bats, which was not the 
case.   
 
The differences in host diversity for henipa- and rubulaviruses might arise from 
varying host spectra. Some genera as for example Avulavirus have a narrow host range 
while others such as Morbillivirus have a broad host range [44]. Therefore it is possible 
that the detection of rubulaviruses in a variety of fruit bat species accounts for a 
generally broader host range of this virus genus compared to henipaviruses. This is 
supported by the detection of rubulaviruses not only in fruit bats but also in 
insectivorous bats [16, 113]. Henipaviruses were detected in fruit bats only, indicating 
a restriction to this host family. It should be mentioned, however, that there is some 
unconfirmed and preliminary evidence for potential existence of henipaviruses in two 
insectivorous bat species [78, 114]. A sampling bias can be excluded as it would have 
affected both genera to the same extend. 
 
Due to the rather clear restriction of henipaviruses with pteropodid bats, virus-host co-
evolution seems at least conceivable. Co-evolution was shown for some DNA viruses 
which deemed to evolve at slower pace, such as the papillomaviruses seemingly co-
evolve with their feline hosts. Here phylogenetic trees of virus and host species are 
topological congruence [115].  
 
An indication for a virus lineage to have evolved (i.e., to stem) from a certain host 
species is if viruses from the host species of interest are simultaneously detected at high 
and deep notes of the virus phylogeny [16]. In my dataset such a double-representation 
could be seen for henipaviruses in E. helvum and, to a much lesser extent, spanning less 
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patristic viral distance, in Rousettus. Those few henipavirus clades from other fruit bats 
which cluster together and are not co-detected in E. helvum might have evolved from 
E. helvum and might still be detectable in Eidolon if the sample size was increased. If we 
accept considerations made in [110], only approximately 85% of henipavirus diversity 
from E. helvum should have been detected in the sample size analyzed in this study. 
However, it needs to be mentioned that the projections as well as the fundamental 
analysis made in that publication are highly controversial, and not widely accepted. 
Likewise it is possible that the virus lineage which was the origin of this cluster is 
already extinct in E. helvum. It should also be considered that the sample volume for 
other fruit bats in this study was large but not equal to that for E. helvum - a bias which 
could not be adjusted for in the limited scope of this virological investigation.  
 
One particular clade of henipaviruses which includes the Australian and Asian 
Hendra- and Nipah virus species is of special interest. Also in this clade, viruses from 
E. helvum were represented, which raises questions regarding a potential African origin 
of henipaviruses. The highest diversity of henipaviruses was detected in Africa 
compared to Asia and Australia. An overlap of habitats between the African and 
Asian bats is known [116], and it is therefore possible that the Asian and Australian 
bats acquired their viruses from Africa originally. More importantly it was shown that 
the African henipaviruses share a conserved GDNQ motif in their RNA-dependent 
RNA polymerase which is thought to be part of the catalytic side for polymerase. This 
motif is shared among most Paramyxoviruses and even most Mononegavirales, therefore 
represents a bona-fide ancestral motif. On the contrary, the Asian henipaviruses have 
an atypical GDNE motif which is also present in some of the Eidolon-associated 
henipaviruses (while other Eidolon-associated henipaviruses have the ancestral motif) 
[16]. This taken together with the virus diversity detected in Africa is indicative of an 
African origin of henipaviruses.  
 
In summary, the data presented here give evidence for a possible co-evolution of 
henipaviruses and E. helvum. However, they do not explain the origin of the 
henipaviruses from other fruit bats. A scenario is imaginable where henipaviruses have 
co-evolved with E. helvum but occasionally transferred to other fruit bat species. The 
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original lineages leading to this events might be invisible to us because they are already 
extinct in E. helvum and/or the new host.  
 
This study was focused on E. helvum and available sequences from other fruit bat 
species are currently not sufficient for extensive phylogenetic calculations. In the 
future, when more sequence information was generated, the calculations done in this 
study should be repeated and complemented with parsimonious calculations to obtain 
a more thoroughly picture of the relation of fruit bats and henipaviruses.  
 
4.2. Transmission of viruses from E. helvum 
 
A variety of viruses were detected in E. helvum but the possibility of spill-over to other 
species is still unclear. Evidence for cross-species transmission is difficult to obtain by 
direct virus detection. Serological investigation of potential target species such as 
livestock or human is required. However, these investigations classically requires a 
virus isolate as surrogate techniques such as viral pseudotypes can only partly display 
the processes of viral neutralization and need to be validated on full virus assays. 
Isolation of paramyxoviruses was attempted but remained unsuccessful, and the lack 
of isolates so far has prevented classification of viruses into serotypes.  
 
In the framework of this study I have used another virus as a surrogate for potential 
virus transmission from Eidolon, namely a rhabdovirus that was isolated from the E. 
helvum colony in Kumasi. The virus was classified in the supergroup of 
dimarhabdoviruses and named Kumasi rhabdovirus (KRV). To obtain indications for 
possible transmission pathways, the virus concentration in all organs was evaluated 
and high detection rates as well as concentrations were found in the spleen. 
Henipaviruses are also present at high concentrations in the spleen and their 
transmission is probably via urine and/or saliva [80, 87]. Urine samples were not 
available at the time of testing but a subset of salivary glands were tested negative for 
KRV. Many rhabdoviruses replicate in the nervous system but KRV was only detected 
at low rates and low concentrations in brains of Eidolon individuals. High detection 
rates of KRV in the spleen and low detection rates in the brain suggests the 
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involvement of the lymphatic system rather than the nervous system in virus infection. 
In contrast, rabies virus was found at high titres in the brain of bats but only to limited 
extent in the spleen [117]. Persistence and long-term replication of viruses in lymphoid 
organs was observed [118] therefore replication of KRV in the spleen is possible. The 
spleen has three main functions, including the proliferation and storage of 
lymphocytes as well as the removal of aged erythrocytes from the blood. In this 
context viral particles may be carried from the blood stream or other compartments 
into the spleen and simply accumulate there. The role of the spleen as a potential place 
of KRV replication therefore needs further confirmation. Histological methods might 
identify virus budding in the spleen to confirm the place of replication. For all E. 
helvum organs, formalin fixed samples are available and offer opportunities for further 
investigation. 
 
Studies of virus transmission require proof of presence of the virus in donor species. In 
our study, the time of sampling encompassed three years and KRV was detected in 
5.1% of the tested animals. The detection rates of KRV coincided with the seasons in 
Ghana, pointing to actual ongoing transmission between bats. During wet seasons 
(March to July and September to November), viral detection rate increased while 
KRV was not detected during the dry Harmattan season (December to February). 
Most hosts develop a permanent protective immunity and virus maintenance depends 
on herd immunity and the recruitment rate of young animals. Accumulation of 
susceptible hosts at nesting colonies can increase virus amplification and the risk of 
transmission and spill-over [119]. This has been shown for other RNA viruses of 
which concentrations and detection rate increased in maternity roosts [120, 121]. The 
detection rate of KRV was significantly higher in juveniles compared to adults but the 
virus concentration remained constant during study time with a mean of 106.44 viral 
RNA copies per gram tissue. For E. helvum, the birth season and the beginning of the 
wet season overlapped but no increase in virus concentration was observed. It seems 
as the virus life-cycle does not depend on the recruitment of susceptible animals. 
 
Phylogenetically, KRV clustered within the supergroup of dimarhabdoviruses of 
which many were isolated from mammals and arthropods and their transmission 
cycles are often maintained by hematophagous arthropods [49, 122]. Considering the 
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observed seasonality, an arthropod transmission of KRV seems possible as an 
alternative option for transmission. However, mosquitoes from close proximity of the 
colony were tested without any evidence for the virus. The collection contained 10 
different mosquito genera with varying numbers per genus. It remains possible that the 
tested sample size was not sufficient for the detection of KRV. On the other hand, the 
vesicular stomatitis virus (VSV) and Chandipura virus (CHPV), as members of the 
dimarhabdovirus supergroup, are transmitted by bites of phlebotomine sand flies [123, 
124] which were not represented in the sampling. However, the vector for many 
dimarhabdoviruses is unknown, encouraging further studies on arthropods as possible 
vectors for the transmission and maintenance of KRV.  
 
In this study the transmission of KRV to mammals was tested on cattle, goat, sheep 
and swine which are the main livestock species in Ghana. Neutralizing antibodies 
were detected in swine samples at low titres (1:10). A challenge when using serology 
as an indicator for past infections in different species, showing cross-species 
transmission, is that neutralizing antibody titers cannot be cross-compared between 
species in the same assay [125, 126]. Furthermore, the sample number for swine sera 
was low. On the other hand, E. helvum samples with low titers were also present and a 
very sensitive and specific PRNT assay was used. The question whether swine are 
infected accidentally and have low titers due to inadequate growth conditions for the 
virus or whether swine are able to host KRV and thus can develop high antibody tires 
should be answered in future studies with a broadened sample set. Thereby a direct 
detection of KRV in the organs and determination of the virus concentration is 
eligibly.  
 
Neutralizing antibodies against KRV were also detected in one human sample. The 
sample originated from a patient of the Komfo Anokye Teaching Hospital in Kumasi 
with unknown clinical history. In cell culture experiments it was shown that KRV 
replicates in primate and humans cells to high titers, however several rhabdoviruses 
replicate to high titres in mammalian cell cultures [51] and it is difficult to draw 
conclusions towards possible hosts from this. In this study, serum samples of zoo 
workers were included, who are in close contact to the E. helvum colony as they live in 
the zoo during their working periods and are thus constantly exposed to urine, faeces 
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and parasites of the bats and also hunt them for control reasons. Therefore they are at 
high risk for acquisition of viruses from the colony. However, none of the zoo workers 
had neutralizing antibodies against KRV. It is therefore questionable if a transmission 
of KRV from bat to human is possible. Different transmission scenarios of KRV are 
imaginable, a direct transmission from bat to human and swine, a transmission from 
swine to human and vice versa, as well as an arthropod transmission between all 
three. Future studies should focus on increased sample sizes and study groups which 
are in close contact to swine.    
 
Cross-neutralization among rhabdoviruses is untypical but possible, as the closely 
related Tibrogargan virus (TIBV) and Coastal plains virus (CPV) exhibit cross-
neutralization [48]. They share an amino acid identity in their structural genes G and 
N of 56%, 67% respectively. KRV is closely related to MEBV and OIRV and clustered 
monophyletic with them. KCV formed a sister clade to the former and was isolated 
from an American Myotis bat, while MEBV and OIRV were isolated from Kenyan 
Rhinolophus bats [58, 127]. Although closely related it was shown that KCV and 
MEBV do not cross-neutralize [128]. Their amino acid identity in the N gene is 43% 
but only partial sequence information are available. On the contrary, KRV, MEBV 
and OIRV shared an amino acid identity in their partial N of 62-66%. Taking the 
amino acid identity of TIBV and CPV into consideration it is thus possible that KRV, 
MEBV and OIRV are cross-neutralizing. Exposure against these or other, as yet 
unidentified viruses might well explain the observed low-level neutralizing antibody 
activities in swine, putting any potential for KRV cross-species transmission into 
perspective. In future studies the focus should be on possible vectors for KRV, 
alternative transmission ways, the role of livestock and humans in the transmission 
cycle of KRV and the consequences of an infection.  
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4.3. Conclusions 
4.3.1. Outcomes and future fields of research  
 
E. helvum fruit bats carry a large diversity of henipa- and rubulaviruses, matching their 
migratory behaviour and dense community structure. These properties may promote 
virus acquisition, maintenance, and transmission to humans or livestock. Predictive 
life history traits could be used as indicators for the assessment of zoonotic risks 
associated with target species. However, it should be noted that the sampling in this 
and other virological investigations has been opportunistic with variations of the 
contribution of species to the sample determined by variation in trapping success. 
Unevenness in sampling is likely to be mirrored in the composition of viral gene 
database entries with uneven representation of viral taxa. A more even and 
phylogenetically representative sample of host taxa might enable assessments of 
ancestral virus-host associations and host change histories along viral evolutionary 
lineages. These in turn could identify actual cross-species viral transmissions.    
 
Transmission of viruses to humans and livestock hosted by E. helvum may be possible 
as exemplified in this study for KRV. These investigations were facilitated through 
incidental isolation of the KRV primary virus from bats, enabling neutralization tests. 
Nevertheless, for a more systematic investigation of potential cross-species 
transmissions of other viruses hosted by E. helvum, neutralization assays based on 
recombinant proteins should be favored over lengthy and uncertain virus isolation 
trials. For the development of neutralization assays established viral pseudotyping 
systems such as the VSV- and HIV-1 vector backbones are available. These systems 
should be used in the future to investigate potential transmission E. helvum - associated 
henipa- and rubulaviruses as identified during this work, as members of those viral 
genera have been transmitted from bats to humans in other parts of the world, with 
sometimes severe pathogenicity. But also the implications of KRV on livestock and 
humans should be further explored in the future to exclude potential risks. In the past, 
individual cases of hemorrhagic fever in humans caused by so far unknown 
rhabdoviruses were reported. It can be assumed that the diversity of KRV-related 
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rhabdoviruses in E. helvum is considerable higher than known today. It is therefore of 
interest to assess rhabdovirus diversity and investigate their potential of transmission.  
 
4.3.2. Biodiversity research with capacity building in source countries 
 
Biological resources-rich countries in Africa are limited in their resources when it 
comes to basic research. A large part of this work has been conducted in Africa 
together with African co-operation partners, Principal investigators, and co-supervised 
staff and students. With some fundamental infrastructure such as laboratory rooms, 
basic equipment and continuous power supply in place, this study has proven that 
sensitive molecular biology methods such as RT-PCR assays can indeed be 
implemented in an African research setting. A problematic issue encountered during 
this work was the supply of reagents, consumables and other specific supply. Most of 
the materials used in modern molecular biology are not produced on the African 
continent and need to be imported. This creates challenges unknown to PhD students 
in the western world. Advanced payment of shipments are the rule when ordering 
from Africa. Custom procedures can be time-consuming and frustrating. The 
organization of transport to the final destination with maintenance of cooling chains is 
crucial and requires meticulous preparation and supervision. These difficulties will 
only change on the long run. The more projects are established in focused research 
settings such as in Kumasi/Ghana where this work was conducted, the better local 
suppliers can adjust to logistical demands and thereby reduce the organizational effort 
for the individual scientist. Among the greatest benefits in capacity building afforded 
by long-term projects in African research settings is the generation of an environment 
in which know-how and scientific ideas can be exchanged. African scientists can find 
themselves isolated from knowledge transfer that is normal in the western world and 
find it difficult to compete scientifically. The training of young ambitious scientists 
along with the provision of technical equipment will hopefully create a space for the 
development of an independent African scientific elite. Projects like this work provide 
a foundation to translate research-based methodology into more common applications 
such as diagnostic tests serving hospitals. For many of the locally relevant diseases 
diagnostic assays have never been developed, or are not applicable in local laboratories 
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without a research background. Scientific projects covered by research funds can 
substantially improve capacities and capabilities. However, the resources required for 
the provision of services in the medical field need to be provided by local health 
systems.  
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5. Summary 
Bats are increasingly recognized as hosts of viruses which are significant for human 
and domestic health. However, the dynamics of these viruses in their natural hosts 
remain poorly elucidated. In this study, virus diversity and transmission was 
exemplified in two viral families present in the straw-coloured fruit bat (E. helvum).  
 
Virus diversity and dynamics were investigated on the genera Henipa-and Rubulavirus 
of the family Paramyxoviridae. Phylogenetic analysis revealed a high diversity of both 
taxa in African fruit bats. The viruses were shared among other fruit bats to different 
extent and were detected in a variety of African countries. It was shown that the 
majority of these viruses were co-circulating during the sampling time of three years in 
a single bat colony from Kumasi, Ghana. Their potential to cross-species barriers was 
discussed based on their phylogentic relations, but transmission has to be investigated 
in more detail in the future. Viruses were predominantly detected in the spleen, but 
area of replication and transmission ways still need to be investigated. 
 
In the frame of this study, a rhabdovirus named Kumasi rhabdovirus (KRV) was 
isolated and classified into the group of dimarhabdoviruses. Dimarhabdoviruses are 
often transmitted and maintained by arthropod vectors. KRV was detected in 5.1% of 
E. helvum from Kumasi. The virus was predominantly detected in the spleen and viral 
detection rates correlated with rain seasons suggesting an arthropod transmission. 
Serological analyse revealed 6.9% neutralizing antibodies in E. helvum. Cross-species 
transmission of KRV was shown for swine (5.4%) and humans (1.6%) and possible 
transmission ways were discussed.  
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Zusammenfassung 
 
Fledermäuse werden zunehmend als Wirte für Viren die signifikant für Menschen und 
Vieh sind erkannt. Aber die Dynamik dieser Viren in ihren natürlichen Wirten ist 
schlecht verstanden. In dieser Studie, wurde die Virusdiversität und Übertragung an 
zwei Virus Familien aus dem Palmenflughund (E .helvum) dargestellt. 
  
Die Virusdiversität und Dynamik wurde an den Genera Henipa- und Rubulavirus aus 
der Familie der Paramyxoviridae untersucht. Phylogenetische Analysen zeigten eine 
hohe Diversität beider Taxa in afrikanischen Flughunden. Die Viren wurden im 
unterschiedlichen Ausmaß unter den Flughundspezies geteilt und wurden in 
unterschiedlichen afrikanischen Ländern detektiert. Es wurde gezeigt, dass die 
Mehrheit der Viren in einer einzelnen Flughund Kolonie aus Kumasi, Ghana in dem 
Untersuchungszeitraum von drei Jahren zirkulieren. Ihr Potential Spezies Barrieren zu 
überwinden wurde diskutiert anhand von phylogenetischen Beziehungen aber das 
Übertragungspotential muss in der Zukunft weiter untersucht werden. Die Viren 
wurden hauptsächlich in der Milz detektiert aber der Ort der Replikation und die 
Übertragungswege sind noch ungeklärt. 
 
Im Rahmen dieser Studie wurde ein Rhabdovirus, das Kumasi rhabdovirus (KRV) 
genannt wurde, isoliert und in die Gruppe der Dimarhabdoviren eingeordnet. 
Dimarhabdoviren werden häufig von arthropoden Vektoren erhalten und übertragen. 
KRV wurde in 5.1% der E. helvum aus Kumasi detektiert. Das Virus wurde 
hauptsächlich in der Milz gefunden und die Detektionsrate korreliert mit der 
Regenzeit, was auf eine arthropode Übertragung deutet. Serologische Analysen 
zeigten das 6.9% der E. helvum neutralisierende Antikörper besitzen. Die Übertragung 
auf andere Spezies wurde für Schweine (5.4%) und Menschen (1.6%) gezeigt und 
mögliche Übertragungswege diskutiert.  
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7. Abbreviations 
BASV Bas-Congo virus 
BEFV Bovine ephemeral fever virus 
cDNA Complementary DNA 
CHPV Chandipura virus 
CO2 Carbon dioxide 
Congo Republic of the Congo 
CPV Coastal plains virus 
CPE Cytopathic effect 
dATP Desoxyadenosintriphosphat 
dCTP Desoxyribonukleosidtriphosphate 
dGTP Desoxyguanosintriphosphat 
Dimarhabdovirus Dipteran-mammal associated virus 
DMEM Dulbecco's Modified Eagle's Medium 
DNA Deoxyribonucleic acid 
dNTP  Desoxyribonukleosidtriphosphate 
DRC Democratic Republic of the Congo 
dTTP Desoxythymidintriphosphat 
DURV Durham virus 
E. helvum Eidolon helvum 
EDTA Ethylenediaminetetraacetic acid 
ELISA Enzyme linked immunosorbent assay 
FCS Fetal calf Serum 
G Glycoprotein 
HCl Chloric acid 
ICTV International Committee on Taxonomy of Viruses 
IFA Indirect immunofluorescence assay  
IHNV Infectious hematopoietic necrosis virus 
KCV Kern Canyon virus 
KOTV Kotonkan virus 
KRV Kumasi rhabdovirus 
L Large protein 
LBV Lagos bat virus 
LNYV Lettuce necrotic yellows virus 
MARAV Maraba virus 
MEBV Mount Elgon virus 
MEM Minimal essential medium 
MgCl2 Magnesiumchloride 
MgSO4 Magnesiumsulfate 
MOI Multiplicity of infection 
MOUV Moussa virus 
MSPV Malpais spring virus 
N Nucleocapsid 
NaHCO3 Natriumhydrogencarbonat 
NaOH Sodium hydroxide 
NGAV Ngaingan virus 
NISV Nishimuro virus 
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OD Optical density 
OIRV Oita rhabdovirus virus 
ORF Overlapping reading frame 
P Phosphoprotein 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PERV Perinet virus 
Pfa Paraformaldehyde 
PFRV Pike fry virus 
PFU Plaque forming unit 
PRNT Plaque-reduction neutralization assay 
PRV Perch rhabdovirus 
PYDV Potato yellow dwarf virus 
RABV Rabies virus 
RCA Central African Republic 
RNA Ribonucleic acid 
RT-PCR Reverse transcription polymerase chain reaction 
SARS Severe acute respiratory syndrome 
SIGMAV Drosophila melanogaster sigma virus, 
TIBV Tibrogargan virus 
TMB 3,3’,5,5’-Tetramethylbenzidine 
Tris Tris hydroxymethyl aminomethane 
TRV Tench virus 
TUPV Tupaia rhabdovirus 
VSINV Vesicular stomatitis Indiana virus 
VSV Vesiculo Stomatitis virus 
WHO The World Health Organization 
WONV Wongabel virus 
β-propiolacton Beta-propiolacton 
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